Luminar (LAZR) 10-Q 6 May 22 2022 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Mar. 31, 2022	Apr. 29, 2022
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2022
Document Transition Report	false
Entity File Number	001-38791
Entity Registrant Name	Luminar Technologies, Inc./DE
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	83-1804317
Entity Address, Address Line One	2603 Discovery Drive
Entity Address, Address Line Two	Suite 100
Entity Address, City or Town	Orlando
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	32826
City Area Code	407
Local Phone Number	900-5259
Title of 12(b) Security	Class A common stock, par value of $0.0001 per share
Trading Symbol	LAZR
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0001758057
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q1
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Class A Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		252,526,777
Class B Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		97,088,670

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 159,416	$ 329,977
Restricted cash	710	725
Marketable securities (including $12,250 and $12,200 with a related party as of March 31, 2022 and December 31, 2021, respectively, see Note 15)	547,440	462,141
Accounts receivable	3,256	13,013
Inventory	10,012	10,342
Prepaid expenses and other current assets	37,545	29,195
Total current assets	758,379	845,393
Property and equipment, net	16,437	11,009
Operating lease right-of-use assets	14,005	9,145
Intangible assets, net	2,361	2,424
Goodwill	2,945	3,110
Other non-current assets	13,673	12,455
Total assets	807,800	883,536
Current liabilities:
Accounts payable	17,293	14,419
Accrued and other current liabilities	24,848	19,844
Operating lease liabilities	5,079	4,735
Total current liabilities	47,220	38,998
Warrant liabilities	16,399	31,230
Convertible senior notes	609,766	608,957
Operating lease liabilities, non-current	10,102	5,768
Other non-current liabilities	429	598
Total liabilities	683,916	685,551
Commitments and contingencies (Note 13)
Stockholders’ equity:
Additional paid-in capital	1,314,742	1,257,214
Accumulated other comprehensive loss	(4,556)	(908)
Treasury stock	(275,519)	(235,871)
Accumulated deficit	(910,820)	(822,487)
Total stockholders’ equity	123,884	197,985
Total liabilities and stockholders’ equity	807,800	883,536
Class A Common Stock
Stockholders’ equity:
Common stock	27	27
Class B Common Stock
Stockholders’ equity:
Common stock	$ 10	$ 10

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Marketable securities	$ 547,440	$ 462,141
Related party
Marketable securities	$ 12,250	$ 12,200

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Total revenue	$ 6,855	$ 5,313
Total cost of sales	16,654	7,639
Gross loss	(9,799)	(2,326)
Operating expenses:
Research and development	33,109	14,010
Sales and marketing	9,398	2,635
General and administrative	30,025	10,273
Total operating expenses	72,532	26,918
Loss from operations	(82,331)	(29,244)
Change in fair value of warrant liabilities	(3,857)	(46,649)
Interest expense and other	(3,280)	(200)
Interest income and other	1,539	170
Total other income (expense), net	(5,598)	(46,679)
Loss before provision for income taxes	(87,929)	(75,923)
Provision for income taxes	404	0
Net loss	$ (88,333)	$ (75,923)
Net loss per share:
Basic (in dollars per share)	$ (0.25)	$ (0.23)
Diluted (in dollars per share)	$ (0.25)	$ (0.23)
Shares used in computing net loss per share:
Basic (in shares)	348,683,836	332,987,523
Diluted (in shares)	348,683,836	332,987,523
Comprehensive Loss:
Net loss	$ (88,333)	$ (75,923)
Net unrealized losses on available-for-sale debt securities	(3,648)	(43)
Comprehensive loss	(91,981)	(75,966)
Products
Total revenue	1,541	2,933
Total cost of sales	11,818	5,309
Services
Total revenue	5,314	2,380
Total cost of sales	$ 4,836	$ 2,330

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Treasury Stock	Accumulated Deficit	Class A Common Stock	Class A Common StockCommon Stock	Class B Common Stock	Class B Common StockCommon Stock
Beginning balance at Dec. 31, 2020	$ 148,741	$ 733,175	$ 34	$ 0	$ (584,501)		$ 22		$ 11
Beginning balance (in shares) at Dec. 31, 2020							218,818,037		105,118,203,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A common stock upon exercise of warrants (in shares)							15,574,037
Issuance of Class A common stock upon exercise of warrants	492,220	492,219					$ 1
Issuance of Class A common stock upon exercise of stock options (in shares)							183,918
Issuance of Class A common stock upon exercise of stock options	322	322
Share-based compensation	1,843	1,843
Other comprehensive loss	(43)		(43)
Net loss	(75,923)				(75,923)
Ending balance at Mar. 31, 2021	567,160	1,227,559	(9)	0	(660,424)		$ 23		$ 11
Ending balance (in shares) at Mar. 31, 2021							234,575,992		105,118,203,000
Beginning balance at Dec. 31, 2021	197,985	1,257,214	(908)	(235,871)	(822,487)		$ 27		$ 10
Beginning balance (in shares) at Dec. 31, 2021							266,076,525		97,088,670
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A common stock upon exercise of warrants (in shares)						401,365
Issuance of Class A common stock upon exercise of warrants	$ 18,689	18,689
Issuance of Class A common stock upon exercise of stock options (in shares)	654,935
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units (in shares)							2,117,059
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units	$ 1,085	1,085
Retirement of unvested restricted common stock (in shares)							(40,763)
Vendor payments in shares in lieu of cash (in shares)							1,424,350
Vendor payments in shares in lieu of cash	14,613	14,613
Share-based compensation	23,657	23,657
Payments of employee taxes related to vested restricted stock units	(516)	(516)
Shares repurchased	(39,648)			(39,648)
Other comprehensive loss	(3,648)		(3,648)
Net loss	(88,333)				(88,333)
Ending balance at Mar. 31, 2022	$ 123,884	$ 1,314,742	$ (4,556)	$ (275,519)	$ (910,820)		$ 27		$ 10
Ending balance (in shares) at Mar. 31, 2022						269,978,536	269,978,536	97,088,670	97,088,670

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net loss	$ (88,333)	$ (75,923)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	805	657
Noncash lease expense related to operating lease right-of-use assets	885	890
Amortization of premium on marketable securities	444	262
Change in fair value of warrants	3,857	46,649
Vendor stock-in-lieu of cash program	7,848	0
Amortization of debt discount and issuance costs	809	0
Impairment of inventories	1,356	257
Share-based compensation	26,698	1,837
Product warranty and other	107	853
Changes in operating assets and liabilities:
Accounts receivable	9,757	3,828
Inventories	(768)	(442)
Prepaid expenses and other current assets	(3,300)	(5,797)
Other non-current assets	158	(1,318)
Accounts payable	5,983	1,766
Accrued and other current liabilities	1,200	(813)
Other non-current liabilities	(343)	(720)
Net cash used in operating activities	(32,837)	(28,014)
Cash flows from investing activities:
Purchases of marketable securities	(193,687)	(226,245)
Proceeds from maturities of marketable securities	91,454	69,275
Proceeds from sales of marketable securities	12,842	29,505
Purchases of property and equipment	(5,004)	(889)
Net cash used in investing activities	(94,395)	(128,354)
Cash flows from financing activities:
Proceeds from exercise of warrants	0	153,927
Proceeds from exercise of stock options	1,092	321
Payments of employee taxes related to vested restricted stock units	(516)	0
Repurchase of common stock and redemption of warrants	(43,920)	(2)
Other financing activities	0	(142)
Net cash provided by (used in) financing activities	(43,344)	154,104
Net decrease in cash, cash equivalents and restricted cash	(170,576)	(2,264)
Beginning cash, cash equivalents and restricted cash	330,702	209,719
Ending cash, cash equivalents and restricted cash	160,126	207,455
Supplemental disclosures of cash flow information:
Cash paid for interest	0	19
Supplemental disclosures of noncash investing and financing activities:
Issuance of Class A common stock upon exercise of warrants	18,689	338,293
Operating lease right-of-use assets obtained in exchange for lease obligations	5,746	2,876
Deferred financing costs recorded in accrued liabilities	0	223
Purchases of property and equipment recorded in accounts payable and accrued liabilities	$ 1,950	504
Accounting Standards Update [Extensible List]	Upon adoption of ASC 842
Upon adoption of ASC 842
Supplemental disclosures of noncash investing and financing activities:
Operating lease right-of-use assets obtained in exchange for lease obligations	$ 0	$ 10,849

Organization and Description of

Organization and Description of Business	3 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	Organization and Description of Business Luminar Technologies, Inc. and its wholly-owned subsidiaries (the “Company” or “Luminar”) was originally incorporated in Delaware on August 28, 2018 under the name Gores Metropoulos, Inc (“Gores”). The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. On December 2, 2020 (the “Closing Date”), the Company (at such time named Gores Metropoulos, Inc.) consummated the business combination (the “Business Combination”) pursuant to the Agreement and Plan of Merger (the “Merger Agreement”), dated August 24, 2020 with the pre-Business Combination Luminar Technologies, Inc. (“Legacy Luminar”). Legacy Luminar was incorporated in Delaware on March 31, 2015. In connection with the consummation of the Business Combination, the Company changed its name from Gores Metropoulos, Inc. to Luminar Technologies, Inc. The Company’s common stock is listed on the NASDAQ under the symbol “LAZR.” The Company’s public warrants to purchase shares of Class A common stock were listed on the NASDAQ under the symbol “LAZRW,” until they were delisted on March 5, 2021 upon exercise and redemption. Unless the context otherwise requires, the “Company” refers to the combined company and its subsidiaries following the Business Combination, “Gores” refers to the Company prior to the Business Combination and “Legacy Luminar” refers to Luminar Technologies, Inc., prior to the Business Combination. Refer to Reverse Merger with Gores in Note 3 to the financial statements of the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 for additional information relating to the Business Combination. The Company is a developer of advanced sensor technologies and software for the autonomous vehicle industry, encompassing Laser Imaging, Detection and Ranging (lidar) technology. The Company manufactures and distributes commercial lidar sensors and certain components for the autonomous vehicle industry. The Company is headquartered in Orlando, Florida and has various facilities located in the United States and internationally in Munich, Germany.

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation and Consolidation The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. In the opinion of management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. All intercompany transactions and balances have been eliminated in consolidation. Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, equity, revenues and expenses, and related disclosures. The significant estimates made by management include inventory reserves, valuation allowance for deferred tax assets, valuation of warrants, forecasted costs associated with non-recurring (“NRE”) services, product warranty reserves, stock-based compensation expense and other loss contingencies. Management periodically evaluates such estimates and they are adjusted prospectively based upon such periodic evaluation. Actual results could differ from those estimates. Segment Information The Company has determined its operating segments using the same indicators which are used to evaluate its performance internally. The Company has two business activities which are its operating segments: (i) “Autonomous Solutions” for automotive applications, which includes manufacturing and distribution of lidar sensors that measure distance using laser light to generate a 3D map, non-recurring engineering services related to the Company’s lidar products, and development of software products that enable autonomy capabilities; and (ii) “Components” which includes development of application-specific integrated circuits, pixel-based sensors, as well as designing, testing and providing consulting services for non-standard integrated circuits. In August 2021, the Company acquired Optogration, Inc. (“Optogration”), which has been included in the Components segment. Concentration of Credit Risk Financial instruments that potentially subject the Company to significant concentrations of credit risk, consist primarily of cash and cash equivalents, marketable investments and accounts receivable. A significant portion of the Company’s cash and cash equivalents is held at high-quality domestic financial institutions. Deposits held with the financial institutions may, at times, exceed the amount of insurance provided on such deposits . Cash held by the Company in foreign entities as of March 31, 2022 and December 31, 2021 was not material. The Company’s revenue is derived from customers located in the United States and international markets. Four customers accounted for 39%, 20%, 11% and 10%, respectively, of the Company’s accounts receivable at March 31, 2022. Two customers accounted for 39% and 31% of the Company’s accounts receivable at December 31, 2021. Significant Accounting Policies The Company’s significant accounting policies are disclosed in its Annual Report on Form 10-K for the year ended December 31, 2021. There has been no material change to the Company’s significant accounting policies during the three months ended March 31, 2022. Recently Adopted Accounting Pronouncements In October 2021, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. No. 2021-08 (“ASU 2021-08”), Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers . ASU 2021-08 requires an acquirer to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. At the acquisition date, it requires an acquirer to account for the related revenue contracts in accordance with Topic 606 as if it had originated the contracts, which should generally result in an acquirer recognizing and measuring the acquired contract assets and contract liabilities consistent with how they were recognized and measured in the acquiree’s financial statements. The Company elected to early adopt ASU 2021-08 as of January 1, 2022. The adoption of ASU 2021-08 did not have a material impact on the Company’s consolidated financial position, operating results or cash flows.

Revenue

Revenue	3 Months Ended
	Mar. 31, 2022
Revenue from Contract with Customer [Abstract]
Revenue	Revenue The Company’s revenue is comprised of sales of lidar sensors hardware, components and NRE services. Disaggregation of Revenues The Company disaggregates its revenue from contracts with customers by (1) geographic region based on customer’s billed to location, and (2) type of good or service and timing of transfer of goods or services to customers (point-in-time or over time), as it believes it best depicts how the nature, amount, timing and uncertainty of its revenue and cash flows are affected by economic factors. Total revenue based on the disaggregation criteria described above, as well as revenue by segment, are as follows (in thousands): Three Months Ended March 31, 2022 2021 Revenue % of Revenue Revenue % of Revenue Revenue by primary geographical market: North America $ 4,968 73 % $ 2,539 48 % Asia Pacific 1,860 27 % 321 6 % Europe and Middle East 27 — % 2,453 46 % Total $ 6,855 100 % $ 5,313 100 % Revenue by timing of recognition: Recognized at a point in time $ 1,541 22 % $ 2,053 39 % Recognized over time 5,314 78 % 3,260 61 % Total $ 6,855 100 % $ 5,313 100 % Revenue by segment: Autonomy Solutions $ 5,898 86 % $ 4,336 82 % Components 957 14 % 977 18 % Total $ 6,855 100 % $ 5,313 100 % Volvo Stock Purchase Warrant In March 2020, the Company issued a stock purchase warrant (“Volvo Warrants”) to Volvo Car Technology Fund AB (“VCTF”) in connection with an engineering services contract. The Volvo Warrants entitle VCTF to purchase up to 4,089,280 shares of Class A common stock, at a price of $3.1769 per share from the Company and were determined to be an equity classified award to VCTF. The Volvo Warrants vest and become exercisable in two tranches based on satisfaction of certain commercial milestones, upon reaching commercial production and delivering of production units. The grant date fair value of warrants, aggregating $2.9 million, represents consideration payable to VCTF and will be recognized as reduction in revenue consistent with the revenue recognition pattern when these warrants become probable of vesting. The Company’s management determined that the vesting of the first of the two tranches of Volvo Warrants was probable as of December 31, 2021. As such, the Company had recognized a reduction in revenue in the amount of $1.0 million related to the said first tranche of the Volvo Warrants in the year ended December 31, 2021. The Company’s management determined that the vesting of the second tranche of Volvo Warrants was not probable as of March 31, 2022. Contract assets and liabilities Contract assets primarily represent revenues recognized for performance obligations that have been satisfied but for which amounts have not been billed. The Company’s contract assets as of March 31, 2022 and December 31, 2021 were $14.8 million and $9.9 million, respectively. Contract liabilities consist of deferred revenue and customer advanced payments. Deferred revenue includes billings in excess of revenue recognized related to product sales and other services revenue and is recognized as revenue when the Company performs under the contract. Customer advanced payments represent required customer payments in advance of product shipments according to customer’s payment term. Customer advance payments are recognized in revenue as or when control of the performance obligation is transferred to the customer. The Company’s contract liabilities were $0.9 million as of March 31, 2022 and December 31, 2021, and were included in accrued and other current liabilities in the condensed consolidated balance sheets. The significant changes in contract assets balances consisted of the following (in thousands): March 31, 2022 December 31, 2021 Beginning balance $ 9,907 $ — Revenue recognized for performance obligations that have been satisfied but for which amounts have not been billed 4,865 9,907 Ending balance $ 14,772 $ 9,907 The significant changes in contract liabilities balances consisted of the following (in thousands): March 31, 2022 December 31, 2021 Beginning balance $ 898 $ 2,284 Revenue recognized that was included in the contract liabilities beginning balance (250) (1,792) Net increase due to cash received and not recognized as revenue and billings in excess of revenue recognized during the period 259 406 Ending balance $ 907 $ 898

Investments

Investments	3 Months Ended
	Mar. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Investments	Investments Debt Securities The Company’s investments in debt securities consisted of the following as of March 31, 2022 and December 31, 2021 (in thousands): March 31, 2022 Cost Gross Gross Fair Value U.S. treasury securities $ 251,673 $ 1 $ (2,685) $ 248,989 U.S. agency and government sponsored securities 4,996 — (89) 4,907 Commercial paper 130,103 1 (126) 129,978 Corporate bonds 158,595 1 (1,348) 157,248 Asset-backed securities 41,185 — (311) 40,874 Total debt securities $ 586,552 $ 3 $ (4,559) $ 581,996 Included in cash and cash equivalents $ 80,201 $ 2 $ (28) $ 80,175 Included in marketable securities 506,351 1 (4,531) 501,821 December 31, 2021 Cost Gross Gross Fair Value U.S. treasury securities $ 161,938 $ 1 $ (474) $ 161,465 U.S. agency and government sponsored securities 4,995 — (25) 4,970 Commercial paper 40,788 — (4) 40,784 Corporate bonds 165,522 13 (345) 165,190 Asset-backed securities 46,540 — (74) 46,466 Total debt securities $ 419,783 $ 14 $ (922) $ 418,875 Included in cash and cash equivalents $ 950 $ — $ — $ 950 Included in marketable securities 418,833 14 (922) 417,925 The following table presents the gross unrealized losses and the fair value for those debt securities that were in an unrealized loss position for less than 12 months as of March 31, 2022 and December 31, 2021 (in thousands): March 31, 2022 December 31, 2021 Gross Fair Value Gross Fair Value U.S. treasury securities $ (2,685) $ 228,993 $ (474) $ 146,454 U.S. agency and government sponsored securities (89) 4,907 (25) 4,970 Commercial paper (126) 114,980 (4) 30,285 Corporate bonds (1,348) 156,246 (345) 145,522 Asset-backed securities (311) 40,874 (74) 45,251 Total $ (4,559) $ 546,000 $ (922) $ 372,482 Equity Investments The Company’s equity investments consisted of the following as of March 31, 2022 and December 31, 2021 (in thousands): Condensed Consolidated Balance Sheets Location March 31, 2022 December 31, 2021 Money market funds (1) Cash and cash equivalents $ 47,497 $ 25,654 Marketable equity investments (1) Marketable securities 45,619 $ 44,216 Non-marketable equity investment measured using the measurement alternative (2) Other non-current assets $ 10,002 $ 10,002 Total $ 103,118 $ 79,872 (1) Investments with readily determinable fair values. (2) Investment in privately held company without readily determinable fair value. In December 2021, the Company made an investment in 1,495 Class A Preferred Units of Robotic Research OpCo, LLC (“Robotic Research”) for consideration of $10.0 million, which was settled by issuing 618,924 shares of Class A common stock of the Company. The Company’s investment in Robotic Research represents less than 5% of Robotic Research’s capitalization. The Company neither has a significant influence over Robotic Research nor does its investment amount to a controlling financial interest in Robotic Research. As such, the Company measured the investment in Robotic Research at cost as provided under the guidance for measurement of equity investment using the measurement alternative. Total realized and unrealized gains and losses associated with the Company’s equity investments was not material in the three months ended March 31, 2022 and 2021.

Financial Statement Components

Financial Statement Components	3 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Financial Statement Components	Financial Statement Components Cash and Cash Equivalents Cash and cash equivalents consisted of the following (in thousands): March 31, 2022 December 31, 2021 Cash $ 31,744 $ 303,373 Money market funds 47,497 25,654 U.S. treasury securities 19,997 — Commercial paper 60,178 950 Total cash and cash equivalents $ 159,416 $ 329,977 Inventories, net Inventories consisted of the following (in thousands): March 31, 2022 December 31, 2021 Raw materials $ 6,535 $ 5,866 Work-in-process 2,265 1,171 Finished goods 1,212 3,305 Total inventories, net $ 10,012 $ 10,342 The Company’s inventory write-down (primarily due to obsolescence, lower of cost or market assessment, and other adjustments) was $1.4 million and $0.3 million for the three months ended March 31, 2022 and 2021, respectively. Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consisted of the following (in thousands): March 31, 2022 December 31, 2021 Prepaid expenses $ 15,893 $ 14,651 Contract assets 14,772 9,907 Advance payments to vendors 4,417 1,810 Other receivables 2,463 2,827 Total prepaid expenses and other current assets $ 37,545 $ 29,195 Property and Equipment Property and equipment consisted of the following (in thousands): March 31, 2022 December 31, 2021 Machinery and equipment $ 8,286 $ 7,694 Computer hardware and software 2,871 2,854 Leasehold improvements 885 869 Vehicles, including demonstration fleet 2,631 2,421 Furniture and fixtures 829 272 Construction in progress 8,454 3,677 Total property and equipment 23,956 17,787 Accumulated depreciation and amortization (7,519) (6,778) Total property and equipment, net $ 16,437 $ 11,009 Property and equipment capitalized under finance lease (capital lease prior to adoption of ASC 842) were not material. Depreciation and amortization expense associated with property and equipment was $0.7 million and $0.7 million for the three months ended March 31, 2022 and 2021, respectively. Intangible Assets The following table summarizes the activity in the Company’s intangible assets during the three months ended March 31, 2022 (in thousands): Three Months Beginning of the period $ 2,424 Amortization (63) End of the period $ 2,361 The components of intangible assets were as follows (in thousands): March 31, 2022 December 31, 2021 Gross Accumulated Net Weighted Average Gross Accumulated Net Weighted Customer relationships $ 780 $ (52) $ 728 9.3 $ 780 $ (33) $ 747 9.6 Tradename 120 (120) — — 120 (120) — — Developed technology 1,750 (117) 1,633 9.3 1,750 (73) 1,677 9.6 Total intangible assets $ 2,650 $ (289) $ 2,361 9.3 $ 2,650 $ (226) $ 2,424 9.6 Amortization expense related to intangible assets was $0.1 million and $0.0 million for the three months ended March 31, 2022 and 2021, respectively. As of March 31, 2022, the expected future amortization expense for intangible assets was as follows (in thousands): Period Expected Future Remaining 2022 $ 190 2023 253 2024 253 2025 253 2026 253 Thereafter 1,159 Total $ 2,361 Goodwill The carrying amount of goodwill allocated to the Company’s reportable segments was as follows (in thousands): Autonomy Solutions Components Total As of March 31, 2022 $ 687 $ 2,258 $ 2,945 As of December 31, 2021 $ 687 $ 2,423 $ 3,110 Other Non-Current Assets Other non-current assets consisted of the following (in thousands): March 31, 2022 December 31, 2021 Security deposits $ 2,574 $ 1,187 Non-marketable equity investment 10,002 10,002 Other non-current assets 1,097 1,266 Total other non-current assets $ 13,673 $ 12,455 Accrued and Other Current Liabilities Accrued and other current liabilities consisted of the following (in thousands): March 31, 2022 December 31, 2021 Accrued compensation and benefits $ 13,755 $ 9,899 Accrued expenses 6,431 6,727 Warranty reserves 1,401 1,798 Accrued interest payable 2,242 316 Other 1,019 1,104 Total accrued and other current liabilities $ 24,848 $ 19,844

Convertible Senior Notes and Ca

Convertible Senior Notes and Capped Call Transactions	3 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
Convertible Senior Notes and Capped Call Transactions	Convertible Senior Notes and Capped Call Transactions In December 2021, the Company issued $625.0 million aggregate principal amount of 1.25% Convertible Senior Notes due 2026 in a private placement, which included $75.0 million aggregate principal amount of such notes pursuant to the exercise in full of the option granted to the initial purchasers to purchase additional notes (collectively, the “Convertible Senior Notes”). The interest on the Convertible Senior Notes is payable semi-annually in arrears on June 15 and December 15 of each year, beginning on June 15, 2022. The Convertible Notes will mature on December 15, 2026, unless earlier repurchased or redeemed by the Company or converted pursuant to their terms. The total net proceeds from the debt offering, after deducting fees paid to the initial purchasers paid by the Company was approximately $609.4 million. Each $1,000 principal amount of the Convertible Senior Notes is initially convertible into 50.0475 shares of the Company’s Class A common stock, par value $0.0001, which is equivalent to an initial conversion price of approximately $19.98 per share. The conversion rate is subject to adjustment upon the occurrence of certain specified events prior to the maturity date but will not be adjusted for any accrued and unpaid interest. In addition, following certain corporate events that occur prior to the maturity date or if the Company delivers a notice of redemption in respect of some or all of the Convertible Senior Notes, the Company will, under certain circumstances, increase the conversion rate of the Convertible Senior Notes for a holder who elects to convert its Convertible Senior Notes in connection with such a corporate event or convert its Convertible Senior Notes called for redemption during the related redemption period, as the case may be. The Convertible Senior Notes are redeemable, in whole or in part (subject to certain limitations), at the Company’s option at any time, and from time to time, on or after December 20, 2024, and on or before the 40th scheduled trading day immediately before the maturity date, at a cash redemption price equal to the principal amount of the Convertible Senior Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date, but only if certain liquidity conditions are satisfied and the last reported sale price per share of the Class A common stock exceeds 130% of the conversion price on (1) each of at least 20 trading days, whether or not consecutive, during the 30 consecutive trading days ending on, and including, the trading day immediately before the date the Company sends the related redemption notice, and (2) the trading day immediately before the date the Company sends such notice. If the Company undergoes a fundamental change (as defined in the indenture governing the Convertible Senior Notes) prior to the maturity date, holders may require the Company to repurchase for cash all or any portion of their Convertible Senior Notes in principal amounts of $1,000 or a multiple thereof at a fundamental change repurchase price equal to 100% of the principal amount of the Convertible Senior Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. Holders of the Convertible Senior Notes may convert their Convertible Senior Notes at their option at any time prior to the close of business on the business day immediately preceding December 15, 2026, in multiples of $1,000 principal amount, only under the following circumstances: (1) during any calendar quarter (and only during such calendar quarter) commencing after the calendar quarter ending on March 31, 2022, if the last reported sale price per share of the Class A common stock exceeds 130% of the conversion price for each of at least 20 trading days, whether or not consecutive, during the 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter; (2) during the five consecutive business days immediately after any 10 consecutive trading day period (such 10 consecutive trading day period, the “measurement period”) in which the trading price per $1,000 principal amount of Convertible Senior Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price per share of the Class A common stock on such trading day and the conversion rate on such trading day; (3) upon the occurrence of specified corporate events or distributions on the Class A common stock; and (4) if the Notes are called for redemption. On or after June 15, 2026, holders may convert all or any portion of their Convertible Senior Notes at any time prior to the close of business on the second scheduled trading day immediately preceding the maturity date, regardless of the foregoing circumstances. Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of its Class A common stock or a combination of cash and shares of its Class A common stock, at the Company’s election. As of March 31, 2022, the conditions allowing holders of the Convertible Senior Notes to convert were not met. It is the Company’s current intent to settle the principal amount of its outstanding Convertible Senior Notes in cash and any excess in shares of the Company’s Class A common stock. The Convertible Senior Notes are senior unsecured obligations and will rank equal in right of payment with the Company’s future senior unsecured indebtedness; senior in right of payment to the Company’s future indebtedness that is expressly subordinated to the Convertible Senior Notes; effectively subordinated to the Company’s existing and future secured indebtedness, to the extent of the value of the collateral securing that indebtedness; and structurally subordinated to all existing and future indebtedness and other liabilities, including trade payables, and (to the extent the Company is not a holder thereof) preferred equity, if any, of the Company’s subsidiaries. The Company has classified the Convertible Senior Notes as a non-current liability under the guidance in ASC 470-20, as amended by ASU 2020-06. Debt discount and issuance costs aggregating approximately $16.2 million were initially recorded as a reduction to the principal amount of the Convertible Senior Notes and is being amortized as interest expense on a straight line basis over the contractual terms of the notes. The Company estimates that the difference between amortizing the debt discounts and the issuance costs using the straight line method as compared to using effective interest rate method is immaterial. The net carrying amount of the Convertible Senior Notes was as follows (in thousands): March 31, 2022 December 31, 2021 Principal $ 625,000 $ 625,000 Unamortized debt discount and issuance costs (15,234) (16,043) Net carrying amount $ 609,766 $ 608,957 The following table sets forth the interest expense recognized related to the Convertible Senior Notes (in thousands): Three Months Contractual interest expense $ 1,926 Amortization of debt discount and issuance costs 809 Total interest expense $ 2,735 The remaining term over which the debt discount and issuance costs will be amortized is 4.7 years. Interest expense of $1.9 million is reflected as a component of interest (expense) income, net in the accompanying condensed consolidated statement of operations for the three months ended March 31, 2022. In connection with the offering of the Convertible Senior Notes, the Company entered into privately negotiated capped call option transactions with certain counterparties (the “Capped Calls”). The Capped Calls each have an initial strike price of approximately $19.98 per share, subject to certain adjustments, which corresponds to the initial conversion price of the Convertible Senior Notes. The Capped Calls have initial cap prices of $30.16 per share, subject to certain adjustment events. The Capped Calls are generally intended to reduce the potential dilution to the Class A common stock upon any conversion of the Convertible Senior Notes and/or offset any cash payments the Company is required to make in excess of the principal amount of converted Convertible Senior Notes, as the case may be, with such reduction and/or offset subject to a cap based on the cap price. The Capped Calls expire on April 6, 2027, subject to earlier exercise. The Capped Calls are subject to either adjustment or termination upon the occurrence of specified extraordinary events affecting the Company, including a merger event, a tender offer, and a nationalization, insolvency or delisting involving the Company. In addition, the Capped Calls are subject to certain specified additional disruption events that may give rise to a termination of the Capped Calls, including changes in law, failure to deliver, and hedging disruptions. The Capped Calls are recorded in stockholders’ equity and are not accounted for as derivatives. The net cost of $73.4 million incurred to purchase the Capped Calls was recorded as a reduction to additional paid-in capital in the accompanying consolidated balance sheet.

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements As of March 31, 2022, the Company carried cash equivalents, marketable investments and Private Warrants. The Company had previously carried Public Warrants which were exercised and redeemed in March 2021. Fair value is based on the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement: Level 1 — Observable inputs, which include unadjusted quoted prices in active markets for identical assets or liabilities. Level 2 — Observable inputs other than Level 1 inputs, such as quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 — Unobservable inputs that are supported by little or no market activity and that are based on management’s assumptions, including fair value measurements determined by using pricing models, discounted cash flow methodologies or similar techniques. The Company determined the fair value of its Level 1 financial instruments, which are traded in active markets, using quoted market prices for identical instruments. Marketable investments classified within Level 2 of the fair value hierarchy are valued based on other observable inputs, including broker or dealer quotations, alternative pricing sources or U.S. Government Treasury yield of appropriate term. When quoted prices in active markets for identical assets or liabilities are not available, the Company relies on non-binding quotes from its investment managers, which are based on proprietary valuation models of independent pricing services. These models generally use inputs such as observable market data, quoted market prices for similar instruments, historical pricing trends of a security as relative to its peers. To validate the fair value determination provided by its investment managers, the Company reviews the pricing movement in the context of overall market trends and trading information from its investment managers. The Company performs routine procedures such as comparing prices obtained from independent source to ensure that appropriate fair values are recorded. Given that the transfer of Private Warrants to anyone outside of a small group of individuals constituting the sponsors of Gores Metropoulos, Inc. would result in the Private Warrants having substantially the same terms as the Public Warrants, management determined that the fair value of each Private Warrant is the same as that of a Public Warrant, with an insignificant adjustment for short-term marketability restrictions, as of December 31, 2021. As of March 31, 2022, management determined the fair value of the Private Warrants using observable inputs in the Black-Scholes valuation model, which used the remaining term of warrants of 3.68 years, volatility of 75.6% and a risk-free rate of 2.44%. Accordingly, the Private Warrants are classified as Level 3 financial instruments. The following table presents changes in Level 3 liabilities relating to Private Warrants measured at fair value (in thousands): Private Warrants Balance as of December 31, 2021 $ 31,230 Change in fair value prior to exercise in January 2022 4,586 Exercises in January 2022 (18,688) Other measurement adjustments (729) Balance as of March 31, 2022 $ 16,399 The Company’s financial assets and liabilities subject to fair value measurements on a recurring basis and the level of inputs used for such measurements were as follows (in thousands): Fair Value (in thousands) Measured as of Level 1 Level 2 Level 3 Total Assets: Cash equivalents: Money market funds $ 47,497 $ — $ — $ 47,497 U.S. treasury securities 19,997 — — 19,997 Commercial paper — 60,178 — 60,178 Total cash equivalents $ 67,494 $ 60,178 $ — $ 127,672 Marketable investments: U.S. treasury securities $ 228,992 $ — $ — $ 228,992 U.S. agency and government sponsored securities — 4,907 — 4,907 Commercial paper — 69,800 — 69,800 Corporate bonds — 157,248 — 157,248 Asset-backed securities — 40,874 — 40,874 Equity investments 45,619 — — 45,619 Total marketable investments $ 274,611 $ 272,829 $ — $ 547,440 Liabilities: Private Warrants $ — $ — $ 16,399 $ 16,399 Total warrant liabilities $ — $ — $ 16,399 $ 16,399 Fair Value (in thousands) Measured as of Level 1 Level 2 Level 3 Total Assets: Cash equivalents: Money market funds $ 25,654 $ — $ — $ 25,654 Commercial paper — 950 — 950 Total cash equivalents $ 25,654 $ 950 $ — $ 26,604 Marketable investments: U.S. treasury securities $ 161,465 $ — $ — $ 161,465 U.S. agency and government sponsored securities — 4,970 — 4,970 Commercial paper — 39,834 — 39,834 Corporate bonds — 165,190 — 165,190 Asset-backed securities — 46,466 — 46,466 Marketable equity investments 44,216 — — 44,216 Total marketable investments $ 205,681 $ 256,460 $ — $ 462,141 Liabilities: Private Warrants — — 31,230 31,230 Total warrant liabilities $ — $ — $ 31,230 $ 31,230 As of March 31, 2022 and December 31, 2021, the estimated fair value of the Company’s outstanding Convertible Senior Notes was $631.9 million and $669.4 million, respectively. The fair value was determined based on the quoted price of the Convertible Senior Notes in an inactive market on the last trading day of the reporting period and have been classified as Level 2 in the fair value hierarchy. See Note 6 for further information on the Company’s Convertible Senior Notes. The Company’s other financial instruments’ fair value, including accounts receivable, accounts payable and other current liabilities, approximate its carrying value due to the relatively short maturity of those instruments. The carrying amounts of the

Earnings (Loss) Per Share

Earnings (Loss) Per Share	3 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Earnings (Loss) Per Share	Earnings (Loss) Per Share Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share is computed by dividing net income by the weighted average number of shares of common stock during the period plus, common stock equivalents, as calculated under the treasury stock method, outstanding during the period. If the Company reports a net loss, the computation of diluted loss per share excludes the effect of dilutive common stock equivalents, as their effect would be antidilutive. The Company computes earnings (loss) per share using the two-class method for its Class A and Class B common stock. Earnings (loss) per share is same for both Class A and Class B common stock since they are entitled to the same liquidation and dividend rights. The following table sets forth the computation of basic and diluted loss per share for the three months ended March 31, 2022 and 2021 (in thousands, except for share and per share amounts): Three Months Ended March 31, 2022 2021 Numerator: Net loss $ (88,333) $ (75,923) Denominator: Weighted average common shares outstanding- Basic 348,683,836 332,987,523 Weighted average common shares outstanding- Diluted 348,683,836 332,987,523 Net loss per shares attributable to common shareholders- Basic and Diluted $ (0.25) $ (0.23) The following table presents the potential shares of Common Stock outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been antidilutive: March 31, 2022 Warrants 5,776,772 Stock options 10,187,197 Restricted stock awards and restricted stock units 15,077,199 Liability classified RSUs 2,628,407 Vendor stock-in-lieu of cash program 833,173 Convertible Senior Notes 31,279,716 Earn-out shares 8,606,717 Total 74,389,181

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	Mar. 31, 2022
Equity [Abstract]
Stockholders' Equity	Stockholders’ Equity Class A and Class B Common Stock The Company’s Board of Directors has authorized two classes of common stock, Class A and Class B. As of March 31, 2022, the Company had authorized 715,000,000 and 121,000,000 shares of Class A and Class B common stock with a par value of $0.0001 per share for each class. As of March 31, 2022, the Company had 269,978,536 and 97,088,670 shares of Class A and Class B common stock issued and outstanding, respectively. Holders of the Class A and Class B common stock have identical rights, except that holders of the Class A common stock are entitled to one vote per share and the holder of the Class B common stock is entitled to ten votes per share. Public and Private Warrants As of December 31, 2021, the Company had no Public Warrants and 3,077,021 Private Warrants outstanding. In January 2022, 1,389,529 Private Warrants were exercised on a cashless basis and the Company issued 401,365 shares of Class A common stock pursuant to the exercises. The Company had 1,687,492 Private Warrants outstanding as of March 31, 2022. These Private Warrants are set to expire on December 2, 2025. Each Private Warrant allows the holder to purchase one share of Class A common stock at $11.50 per share. Stock-in-lieu of Cash Program The Company has entered into arrangements with certain vendors and other third parties wherein the Company at its discretion may elect to compensate the respective vendors / third parties for services provided in either cash or by issuing shares of the Company’s Class A common stock (“Stock-in-lieu of Cash Program”). During the three months ended March 31, 2022, the Company issued 674,350 shares of Class A common stock as part of the Stock-in-lieu of Cash Program. The Company considers the shares issuable under the Stock-in-lieu of Cash Program as liability classified awards when the arrangement with the vendors requires the Company to issue a variable number of shares to settle amounts owed. As of March 31, 2022, the Company had a total of $2.5 million in prepaid expenses and other current and non-current assets related to its Stock-in-lieu of Cash Program. In November 2021, the Company entered into an agreement with Daimler North America Corporation (“Daimler”) wherein Daimler will be providing certain data and other services. To compensate Daimler for these services, the Company agreed to issue 1.5 million shares of Class A common stock to Daimler. These shares vest over a period of two years. The Company recorded costs related to these shares as research and development expense of $2.0 million during the three months ended March 31, 2022. During the three months ended March 31, 2022, the Company issued 750,000 shares of Class A common stock related to this arrangement. The unamortized cost relating to the shares issued to Daimler under this agreement was recorded as $9.2 million in prepaid expenses and other current and non-current assets as of March 31, 2022. The Company’s vendor Stock-in-lieu of Cash Program activity for the three months ended March 31, 2022 was as follows: Shares Weighted Average Outstanding as of December 31, 2021 1,500,000 $ 15.72 Granted 674,350 12.93 Vested (1,424,350) 14.09 Outstanding as of March 31, 2022 750,000 15.72

Stock-based Compensation

Stock-based Compensation	3 Months Ended
	Mar. 31, 2022
Share-based Payment Arrangement [Abstract]
Stock-based Compensation	Stock-based Compensation Prior to becoming a publicly traded entity, the Company issued incentive stock options, non-qualified stock options, and restricted stock to employees and non-employee consultants under its 2015 Stock Plan (the “2015 Plan”). Since the closing of the Business Combination, the Company has not issued any new stock-based awards under the 2015 Plan. In December 2020, the Company’s Board adopted and the Company’s stockholders approved the 2020 Equity Incentive Plan (the “2020 Plan”). The 2020 Plan became effective upon the closing of the Business Combination. Under the 2020 Plan, as of March 31, 2022, the Company was authorized to issue a maximum number of 36,588,278 shares of Class A common stock. Stock Options Under the terms of the 2015 Plan, incentive stock options had an exercise price at or above the fair market value of the stock on the date of the grant, while non-qualified stock options were permitted to be granted below fair market value of the stock on the date of grant. Stock options granted have service-based vesting conditions only. The service-based vesting conditions vary, though typically, stock options vest over four years with 25% of stock options vesting on the first anniversary of the grant and the remaining 75% vesting monthly over the remaining 36 months. Option holders have a 10-year period to exercise their options before they expire. Forfeitures are recognized in the period of occurrence. A summary of the Company’s stock option activity for the nine months ended March 31, 2022 was as follows: Number of Weighted- Weighted- Aggregate Outstanding as of December 31, 2021 11,507,643 $ 1.72 Exercised (654,935) 1.67 Cancelled/Forfeited (665,511) 1.67 Outstanding as of March 31, 2022 10,187,197 1.73 7.50 $ 143,555 The aggregate intrinsic value of stock options exercised during the three months ended March 31, 2022 was $8.3 million. The intrinsic value is calculated as the difference between the exercise price and the fair value of the common stock on the exercise date. The total grant-date fair value of the options vested was $0.8 million during the three months ended March 31, 2022. Restricted Stock Awards Prior to June 30, 2019, the Company granted restricted stock awards to employees. Recipients purchased the restricted stock on the grant date and the Company has the right to repurchase the restricted shares at the same price recipients paid to obtain those shares. The restrictions lapse solely based on continued service, and generally lapse over 4 years —25% on the first anniversary of the date of issuance, and the remaining 75% monthly over the remaining 36 months. At the grant date of the award, recipients of restricted stock are granted voting rights and receive dividends on unvested shares. No restricted stock awards have been granted after June 30, 2019. Restricted stock awards activity for the three months ended March 31, 2022 was as follows: Shares Weighted Average Outstanding as of December 31, 2021 666,298 $ 1.21 Forfeited (11,783) 1.22 Vested (168,144) 1.16 Outstanding as of March 31, 2022 486,371 1.23 Restricted Stock units The Company has been granting restricted stock units (“RSUs”) under the 2020 Plan. Each RSU granted under the 2020 Plan represents a right to receive one share of the Company’s Class A common stock when the RSU vests. RSUs generally vest over a period up to six years. The fair value of RSU is equal to the fair value of the Company’s common stock on the date of grant. A summary of the Company’s restricted stock units activity for the three months ended March 31, 2022 was as follows: Shares Weighted Average Outstanding as of December 31, 2021 11,983,032 $ 19.56 Granted 4,429,640 14.10 Forfeited (326,912) 17.94 Vested (1,494,932) 19.48 Outstanding as of March 31, 2022 14,590,828 17.92 Fixed Value Equity Awards The Company issues fixed value equity awards to certain employees as a part of their compensation package. These awards are issued as RSUs out of the 2020 EIP and are accounted for as liability classified awards under ASC 718 — Stock Compensation. Fixed value equity awards granted have service-based conditions only and vest quarterly over a period of four years. These awards represent a fixed dollar amount settled in a variable number of shares determined at each vesting period. For the three months ended March 31, 2022 and 2021, the Company recorded $1.8 million and $0.0 million, respectively, in stock-based compensation expense related to these awards. Optogration Awards As part of the Optogration acquisition in August 2021, the Company owes up to $22.0 million of post combination compensation related to certain service and performance conditions. As of March 31, 2022, it is probable that the conditions will be met, and as a result, the Company recorded $9.1 million in stock-based compensation expense through March 31, 2022. Compensation expense Stock-based compensation expense by function was as follows (in thousands): Three Months Ended March 31, 2022 2021 Cost of sales $ 1,786 $ 83 Research and development 7,102 762 Sales and marketing 2,868 186 General and administrative 14,942 806 Total $ 26,698 $ 1,837 Stock-based compensation expense by type of award was as follows (in thousands): Three Months Ended March 31, 2022 2021 Equity Classified Awards: Stock options $ 522 $ 163 RSAs (166) 1,674 RSUs 21,509 — Liability Classified Awards: Fixed value equity awards 1,780 — Optogration awards 3,053 — Total $ 26,698 $ 1,837

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company had provision for income taxes of $0.4 million and $0.0 million for the three months ended March 31, 2022 and 2021 , respectively. The effective tax rate was 0.5% and 0.0% for the three months ended March 31, 2022 and 2021, respectively . The effective tax rates differ significantly from the statutory tax rate of 21%, primarily due to the Company’s valuation allowance movement in each period presented.

Leases

Leases	3 Months Ended
	Mar. 31, 2022
Leases [Abstract]
Leases	Leases The Company leases office and manufacturing facilities under non-cancelable operating leases expiring at various dates through September 2028. In October 2021, the Company entered into a lease agreement commencing on April 1, 2022 for a term of 65 months through August 31, 2027. Some of the Company’s leases include one or more options to renew, with renewal terms that if exercised by the Company, extend the lease term from one The components of lease expenses for were as follows (in thousands): Three Months Ended March 31, 2022 March 31, 2021 Operating lease cost $ 1,116 $ 1,174 Variable lease cost 385 459 Total operating lease cost $ 1,501 $ 1,633 Supplemental cash flow information related to leases was as follows (in thousands): Three Months Ended March 31, 2022 March 31, 2021 Cash paid for amounts included in the measurement of lease liabilities: Cash paid for operating leases included in operating activities $ (1,314) $ (1,219) Right of use assets obtained in exchange for lease obligations: Operating leases 5,746 2,876 Supplemental balance sheet information related to leases was as follows (in thousands): March 31, 2022 December 31, 2021 Operating leases: Operating lease right-of-use assets $ 14,005 $ 9,145 Operating lease liabilities: Operating lease liabilities, current $ 5,079 $ 4,735 Operating lease liabilities, non-current 10,102 5,768 Total operating lease liabilities $ 15,181 $ 10,503 Weighted average remaining terms were as follows (in years): March 31, 2022 December 31, 2021 Weighted average remaining lease term Operating leases 3.97 2.95 Weighted average discount rates were as follows: March 31, 2022 December 31, 2021 Weighted average discount rate Operating leases 3.62 % 2.80 % Maturities of lease liabilities were as follows (in thousands): Operating Leases Year Ending December 31, 2022 (remaining nine months) $ 3,993 2023 4,591 2024 2,373 2025 2,351 2026 1,795 2027 1,231 Thereafter 800 Total lease payments 17,134 Less: imputed interest (1,953) Total leases liabilities $ 15,181
Leases	Leases The Company leases office and manufacturing facilities under non-cancelable operating leases expiring at various dates through September 2028. In October 2021, the Company entered into a lease agreement commencing on April 1, 2022 for a term of 65 months through August 31, 2027. Some of the Company’s leases include one or more options to renew, with renewal terms that if exercised by the Company, extend the lease term from one The components of lease expenses for were as follows (in thousands): Three Months Ended March 31, 2022 March 31, 2021 Operating lease cost $ 1,116 $ 1,174 Variable lease cost 385 459 Total operating lease cost $ 1,501 $ 1,633 Supplemental cash flow information related to leases was as follows (in thousands): Three Months Ended March 31, 2022 March 31, 2021 Cash paid for amounts included in the measurement of lease liabilities: Cash paid for operating leases included in operating activities $ (1,314) $ (1,219) Right of use assets obtained in exchange for lease obligations: Operating leases 5,746 2,876 Supplemental balance sheet information related to leases was as follows (in thousands): March 31, 2022 December 31, 2021 Operating leases: Operating lease right-of-use assets $ 14,005 $ 9,145 Operating lease liabilities: Operating lease liabilities, current $ 5,079 $ 4,735 Operating lease liabilities, non-current 10,102 5,768 Total operating lease liabilities $ 15,181 $ 10,503 Weighted average remaining terms were as follows (in years): March 31, 2022 December 31, 2021 Weighted average remaining lease term Operating leases 3.97 2.95 Weighted average discount rates were as follows: March 31, 2022 December 31, 2021 Weighted average discount rate Operating leases 3.62 % 2.80 % Maturities of lease liabilities were as follows (in thousands): Operating Leases Year Ending December 31, 2022 (remaining nine months) $ 3,993 2023 4,591 2024 2,373 2025 2,351 2026 1,795 2027 1,231 Thereafter 800 Total lease payments 17,134 Less: imputed interest (1,953) Total leases liabilities $ 15,181

Commitment and Contingencies

Commitment and Contingencies	3 Months Ended
	Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Purchase Obligations The Company purchases goods and services from a variety of suppliers in the ordinary course of business. Purchase obligations are defined as agreements that are enforceable and legally binding and that specify all significant terms, including fixed or minimum quantities to be purchased, fixed, minimum, or variable price provisions, and the approximate timing of the transaction. The Company had purchase obligations primarily for purchases of inventory, R&D, and general and administrative activities totaling $39.1 million as of March 31, 2022, which are expected to be received within a year. In October 2021, the Company entered into an office space lease commencing April 1, 2022. This will commit the Company to total rent payments of $5.0 million and variable costs of $1.4 million through the end of the lease ending August 31, 2027. In June 2021, the Company entered into an agreement with P3 USA, Inc. (“P3”) to provide engineering, and general and administrative services. Under the said agreement, the Company issued 291,940 shares of Class A common stock to P3 in the third quarter of 2021. In September 2021, the Company entered into an amendment to modify the existing agreement with P3 and among other things, extended the term of the agreement until December 2025. The Company has committed a spend of $30.0 million with P3 over the contracted term. Legal Matters From time to time, the Company is involved in actions, claims, suits and other proceedings in the ordinary course of business, including assertions by third parties relating to intellectual property infringement, breaches of contract or warranties or employment-related matters. When it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated, the Company records a liability for such loss contingencies. The Company’s estimates regarding potential losses and materiality are based on the Company’s judgment and assessment of the claims utilizing currently available information. Although the Company will continue to reassess its reserves and estimates based on future developments, the Company’s objective assessment of the legal merits of such claims may not always be predictive of the outcome and actual results may vary from the Company’s current estimates.

Segment and Customer Concentrat

Segment and Customer Concentration Information	3 Months Ended
	Mar. 31, 2022
Segment Reporting [Abstract]
Segment and Customer Concentration Information	Segment and Customer Concentration Information Reportable segments are (i) Autonomy Solutions and (ii) Components. These segments reflect the way the chief operating decision maker (“CODM”) evaluates the Company’s business performance and manages its operations. Each segment has distinct product offerings, customers, and market penetration. The Chief Executive Officer is the CODM of the Company. Autonomy Solutions This segment manufactures and distributes commercial lidar sensors that measure distance using laser light to generate a highly accurate 3D map for automotive mobility applications. This segment is impacted by trends in and the strength of the autonomous vehicles and associated infrastructure/technology sector. Components This segment is in the business of development of ultra-sensitive pixel-based sensors. This segment also designs, tests and provides consulting services for non-standard integrated circuits that are essential for systems to meet the requirement of customers. This segment is impacted by trends in and the strength of automobile and aeronautics sector as well as government spending in military and defense activities. The accounting policies of the operating segments are the same as those described in Note 2. Segment operating results and reconciliations to the Company’s consolidated balances are as follows (in thousands): Three Months Ended March 31, 2022 Autonomy Components Total Eliminations (1) Total Revenue: Revenues from external customers $ 5,898 $ 957 $ 6,855 $ — $ 6,855 Revenues from internal customer 2,361 2,156 4,517 (4,517) — Total revenue $ 8,259 $ 3,113 $ 11,372 $ (4,517) $ 6,855 Depreciation and amortization $ 544 $ 261 $ 805 $ — $ 805 Operating income (loss) (82,177) 270 (81,907) (424) (82,331) Other significant items: Segment assets 815,160 10,992 826,152 (18,352) 807,800 Inventories, net 9,813 199 10,012 — 10,012 Three Months Ended March 31, 2021 Autonomy Components Total Eliminations (1) Total Revenue: Revenues from external customers $ 4,336 $ 977 $ 5,313 $ — $ 5,313 Revenues from internal customer 1,275 1,142 2,417 (2,417) — Total revenue $ 5,611 $ 2,119 $ 7,730 $ (2,417) $ 5,313 Depreciation and amortization $ 638 $ 20 $ 658 $ (1) $ 657 Operating income (loss) (28,868) (237) (29,105) (139) (29,244) Other significant items: Segment assets 650,211 3,708 653,919 (2,705) 651,214 Inventories, net 3,245 38 3,283 — 3,283 (1) Represents the eliminations of all intercompany balances and transactions during the period presented.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2022
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions Equity Investments In February 2021, the Company invested $15.0 million in a special purpose acquisition company, of which Mr. Jun Hong Heng, is the Chairman and Chief Executive Officer, and a principal shareholder. Mr. Heng became a director of the Company in June 2021. The terms of such investment were no less favorable to the Company than to other third party investors. During 2021, the Company sold $2.9 million of this investment and had a remaining balance of $12.1 million as of December 31, 2021. The fair value of this investment as of March 31, 2022 was $12.3 million.

Subsequent Event

Subsequent Event	3 Months Ended
	Mar. 31, 2022
Subsequent Events [Abstract]
Subsequent Event	Subsequent Event On March 14, 2022, the Company entered into a stock purchase agreement to acquire all issued and outstanding shares of capital stock of Freedom Photonics LLC (“Freedom Photonics”). The closing consideration was paid in the form of shares of Class A common stock of the Company and additional stock consideration would be due to the sellers if certain post-closing conditions are met. Management is in the process of making a determination whether some or all of the additional consideration is required to be reflected as compensation costs in the post-acquisition periods. The transaction closed on April 13, 2022. The Company is currently finalizing the allocation of the purchase price which is expected to be allocated primarily to goodwill and intangible assets. Freedom Photonics is expected to be included as part of the Company’s Components segment. On May 2, 2022, the Board of Directors of the Company granted an award of 10.8 million RSUs to Austin Russell, the Company’s Chief Executive Officer. This award represents Mr. Russell’s total compensation from the Company, and is subject to all of the following vesting conditions: • Market condition: Upon achievement of stock price of $50 or more, $60 or more, and $70 or more. Stock price will be measured based on volume-weighted average price per share for 90 consecutive trading days; • Service condition: Vesting over 7-years; and • Performance condition: Upon start of production of one series production program.

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Basis of Presentation and Consolidation	Basis of Presentation and Consolidation The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. In the opinion of management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. All intercompany transactions and balances have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, equity, revenues and expenses, and related disclosures. The significant estimates made by management include inventory reserves, valuation allowance for deferred tax assets, valuation of warrants, forecasted costs associated with non-recurring (“NRE”) services, product warranty reserves, stock-based compensation expense and other loss contingencies. Management periodically evaluates such estimates and they are adjusted prospectively based upon such periodic evaluation. Actual results could differ from those estimates.
Segment Information	Segment Information The Company has determined its operating segments using the same indicators which are used to evaluate its performance internally. The Company has two business activities which are its operating segments: (i) “Autonomous Solutions” for automotive applications, which includes manufacturing and distribution of lidar sensors that measure distance using laser light to generate a 3D map, non-recurring engineering services related to the Company’s lidar products, and development of software products that enable autonomy capabilities; and (ii) “Components” which includes development of application-specific integrated circuits, pixel-based sensors, as well as designing, testing and providing consulting services for non-standard integrated circuits. In August 2021, the Company acquired Optogration, Inc. (“Optogration”), which has been included in the Components segment.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to significant concentrations of credit risk, consist primarily of cash and cash equivalents, marketable investments and accounts receivable. A significant portion of the Company’s cash and cash equivalents is held at high-quality domestic financial institutions. Deposits held with the financial institutions may, at times, exceed the amount of insurance provided on such deposits . Cash held by the Company in foreign entities as of March 31, 2022 and December 31, 2021 was not material.
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements In October 2021, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. No. 2021-08 (“ASU 2021-08”), Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers . ASU 2021-08 requires an acquirer to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. At the acquisition date, it requires an acquirer to account for the related revenue contracts in accordance with Topic 606 as if it had originated the contracts, which should generally result in an acquirer recognizing and measuring the acquired contract assets and contract liabilities consistent with how they were recognized and measured in the acquiree’s financial statements. The Company elected to early adopt ASU 2021-08 as of January 1, 2022. The adoption of ASU 2021-08 did not have a material impact on the Company’s consolidated financial position, operating results or cash flows.
Fair Value Measurements	Fair Value Measurements As of March 31, 2022, the Company carried cash equivalents, marketable investments and Private Warrants. The Company had previously carried Public Warrants which were exercised and redeemed in March 2021. Fair value is based on the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement: Level 1 — Observable inputs, which include unadjusted quoted prices in active markets for identical assets or liabilities. Level 2 — Observable inputs other than Level 1 inputs, such as quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 — Unobservable inputs that are supported by little or no market activity and that are based on management’s assumptions, including fair value measurements determined by using pricing models, discounted cash flow methodologies or similar techniques. The Company determined the fair value of its Level 1 financial instruments, which are traded in active markets, using quoted market prices for identical instruments.

Revenue (Tables)

Revenue (Tables)	3 Months Ended
	Mar. 31, 2022
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue	Total revenue based on the disaggregation criteria described above, as well as revenue by segment, are as follows (in thousands): Three Months Ended March 31, 2022 2021 Revenue % of Revenue Revenue % of Revenue Revenue by primary geographical market: North America $ 4,968 73 % $ 2,539 48 % Asia Pacific 1,860 27 % 321 6 % Europe and Middle East 27 — % 2,453 46 % Total $ 6,855 100 % $ 5,313 100 % Revenue by timing of recognition: Recognized at a point in time $ 1,541 22 % $ 2,053 39 % Recognized over time 5,314 78 % 3,260 61 % Total $ 6,855 100 % $ 5,313 100 % Revenue by segment: Autonomy Solutions $ 5,898 86 % $ 4,336 82 % Components 957 14 % 977 18 % Total $ 6,855 100 % $ 5,313 100 %
Schedule of Opening and Closing Balances of Contract Liabilities and Significant Changes in Contract Liabilities	The significant changes in contract assets balances consisted of the following (in thousands): March 31, 2022 December 31, 2021 Beginning balance $ 9,907 $ — Revenue recognized for performance obligations that have been satisfied but for which amounts have not been billed 4,865 9,907 Ending balance $ 14,772 $ 9,907 The significant changes in contract liabilities balances consisted of the following (in thousands): March 31, 2022 December 31, 2021 Beginning balance $ 898 $ 2,284 Revenue recognized that was included in the contract liabilities beginning balance (250) (1,792) Net increase due to cash received and not recognized as revenue and billings in excess of revenue recognized during the period 259 406 Ending balance $ 907 $ 898

Investments (Tables)

Investments (Tables)	3 Months Ended
	Mar. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Debt Securities, Available-for-sale	The Company’s investments in debt securities consisted of the following as of March 31, 2022 and December 31, 2021 (in thousands): March 31, 2022 Cost Gross Gross Fair Value U.S. treasury securities $ 251,673 $ 1 $ (2,685) $ 248,989 U.S. agency and government sponsored securities 4,996 — (89) 4,907 Commercial paper 130,103 1 (126) 129,978 Corporate bonds 158,595 1 (1,348) 157,248 Asset-backed securities 41,185 — (311) 40,874 Total debt securities $ 586,552 $ 3 $ (4,559) $ 581,996 Included in cash and cash equivalents $ 80,201 $ 2 $ (28) $ 80,175 Included in marketable securities 506,351 1 (4,531) 501,821 December 31, 2021 Cost Gross Gross Fair Value U.S. treasury securities $ 161,938 $ 1 $ (474) $ 161,465 U.S. agency and government sponsored securities 4,995 — (25) 4,970 Commercial paper 40,788 — (4) 40,784 Corporate bonds 165,522 13 (345) 165,190 Asset-backed securities 46,540 — (74) 46,466 Total debt securities $ 419,783 $ 14 $ (922) $ 418,875 Included in cash and cash equivalents $ 950 $ — $ — $ 950 Included in marketable securities 418,833 14 (922) 417,925
Schedule of Gross Unrealized Losses and the Fair Value for Marketable Investments	The following table presents the gross unrealized losses and the fair value for those debt securities that were in an unrealized loss position for less than 12 months as of March 31, 2022 and December 31, 2021 (in thousands): March 31, 2022 December 31, 2021 Gross Fair Value Gross Fair Value U.S. treasury securities $ (2,685) $ 228,993 $ (474) $ 146,454 U.S. agency and government sponsored securities (89) 4,907 (25) 4,970 Commercial paper (126) 114,980 (4) 30,285 Corporate bonds (1,348) 156,246 (345) 145,522 Asset-backed securities (311) 40,874 (74) 45,251 Total $ (4,559) $ 546,000 $ (922) $ 372,482
Schedule of Equity Investments Included in Marketable Securities	December 31, 2021 Cost Gross Gross Fair Value U.S. treasury securities $ 161,938 $ 1 $ (474) $ 161,465 U.S. agency and government sponsored securities 4,995 — (25) 4,970 Commercial paper 40,788 — (4) 40,784 Corporate bonds 165,522 13 (345) 165,190 Asset-backed securities 46,540 — (74) 46,466 Total debt securities $ 419,783 $ 14 $ (922) $ 418,875 Included in cash and cash equivalents $ 950 $ — $ — $ 950 Included in marketable securities 418,833 14 (922) 417,925 The following table presents the gross unrealized losses and the fair value for those debt securities that were in an unrealized loss position for less than 12 months as of March 31, 2022 and December 31, 2021 (in thousands): March 31, 2022 December 31, 2021 Gross Fair Value Gross Fair Value U.S. treasury securities $ (2,685) $ 228,993 $ (474) $ 146,454 U.S. agency and government sponsored securities (89) 4,907 (25) 4,970 Commercial paper (126) 114,980 (4) 30,285 Corporate bonds (1,348) 156,246 (345) 145,522 Asset-backed securities (311) 40,874 (74) 45,251 Total $ (4,559) $ 546,000 $ (922) $ 372,482 Equity Investments The Company’s equity investments consisted of the following as of March 31, 2022 and December 31, 2021 (in thousands): Condensed Consolidated Balance Sheets Location March 31, 2022 December 31, 2021 Money market funds (1) Cash and cash equivalents $ 47,497 $ 25,654 Marketable equity investments (1) Marketable securities 45,619 $ 44,216 Non-marketable equity investment measured using the measurement alternative (2) Other non-current assets $ 10,002 $ 10,002 Total $ 103,118 $ 79,872 (1) Investments with readily determinable fair values. (2) Investment in privately held company without readily determinable fair value.

Financial Statement Components

Financial Statement Components (Tables)	3 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Cash and Cash Equivalents	Cash and cash equivalents consisted of the following (in thousands): March 31, 2022 December 31, 2021 Cash $ 31,744 $ 303,373 Money market funds 47,497 25,654 U.S. treasury securities 19,997 — Commercial paper 60,178 950 Total cash and cash equivalents $ 159,416 $ 329,977
Schedule of Inventories, net	Inventories consisted of the following (in thousands): March 31, 2022 December 31, 2021 Raw materials $ 6,535 $ 5,866 Work-in-process 2,265 1,171 Finished goods 1,212 3,305 Total inventories, net $ 10,012 $ 10,342
Schedule of Prepaid Expenses and Other Current Assets	Prepaid expenses and other current assets consisted of the following (in thousands): March 31, 2022 December 31, 2021 Prepaid expenses $ 15,893 $ 14,651 Contract assets 14,772 9,907 Advance payments to vendors 4,417 1,810 Other receivables 2,463 2,827 Total prepaid expenses and other current assets $ 37,545 $ 29,195
Schedule of Property and Equipment and Property and Equipment Capitalized Under Finance Lease (Capital Lease Prior to Adoption of ASC 842)	Property and equipment consisted of the following (in thousands): March 31, 2022 December 31, 2021 Machinery and equipment $ 8,286 $ 7,694 Computer hardware and software 2,871 2,854 Leasehold improvements 885 869 Vehicles, including demonstration fleet 2,631 2,421 Furniture and fixtures 829 272 Construction in progress 8,454 3,677 Total property and equipment 23,956 17,787 Accumulated depreciation and amortization (7,519) (6,778) Total property and equipment, net $ 16,437 $ 11,009 Property and equipment capitalized under finance lease (capital lease prior to adoption of ASC 842) were not material.
Schedule of Finite-Lived Intangible Assets	The following table summarizes the activity in the Company’s intangible assets during the three months ended March 31, 2022 (in thousands): Three Months Beginning of the period $ 2,424 Amortization (63) End of the period $ 2,361 The components of intangible assets were as follows (in thousands): March 31, 2022 December 31, 2021 Gross Accumulated Net Weighted Average Gross Accumulated Net Weighted Customer relationships $ 780 $ (52) $ 728 9.3 $ 780 $ (33) $ 747 9.6 Tradename 120 (120) — — 120 (120) — — Developed technology 1,750 (117) 1,633 9.3 1,750 (73) 1,677 9.6 Total intangible assets $ 2,650 $ (289) $ 2,361 9.3 $ 2,650 $ (226) $ 2,424 9.6
Schedule of Future Amortization Expense	As of March 31, 2022, the expected future amortization expense for intangible assets was as follows (in thousands): Period Expected Future Remaining 2022 $ 190 2023 253 2024 253 2025 253 2026 253 Thereafter 1,159 Total $ 2,361
Schedule of Goodwill	The carrying amount of goodwill allocated to the Company’s reportable segments was as follows (in thousands): Autonomy Solutions Components Total As of March 31, 2022 $ 687 $ 2,258 $ 2,945 As of December 31, 2021 $ 687 $ 2,423 $ 3,110
Schedule of Other Noncurrent Assets	Other non-current assets consisted of the following (in thousands): March 31, 2022 December 31, 2021 Security deposits $ 2,574 $ 1,187 Non-marketable equity investment 10,002 10,002 Other non-current assets 1,097 1,266 Total other non-current assets $ 13,673 $ 12,455
Schedule of Accrued and Other Current Liabilities	Accrued and other current liabilities consisted of the following (in thousands): March 31, 2022 December 31, 2021 Accrued compensation and benefits $ 13,755 $ 9,899 Accrued expenses 6,431 6,727 Warranty reserves 1,401 1,798 Accrued interest payable 2,242 316 Other 1,019 1,104 Total accrued and other current liabilities $ 24,848 $ 19,844

Convertible Senior Notes and _2

Convertible Senior Notes and Capped Call Transactions (Tables)	3 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
Schedule of Net Carrying Amount	The net carrying amount of the Convertible Senior Notes was as follows (in thousands): March 31, 2022 December 31, 2021 Principal $ 625,000 $ 625,000 Unamortized debt discount and issuance costs (15,234) (16,043) Net carrying amount $ 609,766 $ 608,957
Schedule of Interest Expense	The following table sets forth the interest expense recognized related to the Convertible Senior Notes (in thousands): Three Months Contractual interest expense $ 1,926 Amortization of debt discount and issuance costs 809 Total interest expense $ 2,735

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Schedule of Changes in Level 3 Liabilities Measured at Fair Value	The following table presents changes in Level 3 liabilities relating to Private Warrants measured at fair value (in thousands): Private Warrants Balance as of December 31, 2021 $ 31,230 Change in fair value prior to exercise in January 2022 4,586 Exercises in January 2022 (18,688) Other measurement adjustments (729) Balance as of March 31, 2022 $ 16,399
Schedule of Financial Assets and Liabilities Subject to Fair Value Measurements on a Recurring Basis and the Level of Inputs Used	The Company’s financial assets and liabilities subject to fair value measurements on a recurring basis and the level of inputs used for such measurements were as follows (in thousands): Fair Value (in thousands) Measured as of Level 1 Level 2 Level 3 Total Assets: Cash equivalents: Money market funds $ 47,497 $ — $ — $ 47,497 U.S. treasury securities 19,997 — — 19,997 Commercial paper — 60,178 — 60,178 Total cash equivalents $ 67,494 $ 60,178 $ — $ 127,672 Marketable investments: U.S. treasury securities $ 228,992 $ — $ — $ 228,992 U.S. agency and government sponsored securities — 4,907 — 4,907 Commercial paper — 69,800 — 69,800 Corporate bonds — 157,248 — 157,248 Asset-backed securities — 40,874 — 40,874 Equity investments 45,619 — — 45,619 Total marketable investments $ 274,611 $ 272,829 $ — $ 547,440 Liabilities: Private Warrants $ — $ — $ 16,399 $ 16,399 Total warrant liabilities $ — $ — $ 16,399 $ 16,399 Fair Value (in thousands) Measured as of Level 1 Level 2 Level 3 Total Assets: Cash equivalents: Money market funds $ 25,654 $ — $ — $ 25,654 Commercial paper — 950 — 950 Total cash equivalents $ 25,654 $ 950 $ — $ 26,604 Marketable investments: U.S. treasury securities $ 161,465 $ — $ — $ 161,465 U.S. agency and government sponsored securities — 4,970 — 4,970 Commercial paper — 39,834 — 39,834 Corporate bonds — 165,190 — 165,190 Asset-backed securities — 46,466 — 46,466 Marketable equity investments 44,216 — — 44,216 Total marketable investments $ 205,681 $ 256,460 $ — $ 462,141 Liabilities: Private Warrants — — 31,230 31,230 Total warrant liabilities $ — $ — $ 31,230 $ 31,230

Earnings (Loss) Per Share (Tabl

Earnings (Loss) Per Share (Tables)	3 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table sets forth the computation of basic and diluted loss per share for the three months ended March 31, 2022 and 2021 (in thousands, except for share and per share amounts): Three Months Ended March 31, 2022 2021 Numerator: Net loss $ (88,333) $ (75,923) Denominator: Weighted average common shares outstanding- Basic 348,683,836 332,987,523 Weighted average common shares outstanding- Diluted 348,683,836 332,987,523 Net loss per shares attributable to common shareholders- Basic and Diluted $ (0.25) $ (0.23)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following table presents the potential shares of Common Stock outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been antidilutive: March 31, 2022 Warrants 5,776,772 Stock options 10,187,197 Restricted stock awards and restricted stock units 15,077,199 Liability classified RSUs 2,628,407 Vendor stock-in-lieu of cash program 833,173 Convertible Senior Notes 31,279,716 Earn-out shares 8,606,717 Total 74,389,181

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	3 Months Ended
	Mar. 31, 2022
Equity [Abstract]
Vendor Stock-in-lieu of Cash Program	The Company’s vendor Stock-in-lieu of Cash Program activity for the three months ended March 31, 2022 was as follows: Shares Weighted Average Outstanding as of December 31, 2021 1,500,000 $ 15.72 Granted 674,350 12.93 Vested (1,424,350) 14.09 Outstanding as of March 31, 2022 750,000 15.72

Stock-based Compensation (Table

Stock-based Compensation (Tables)	3 Months Ended
	Mar. 31, 2022
Share-based Payment Arrangement [Abstract]
Schedule of Stock Option Activity	A summary of the Company’s stock option activity for the nine months ended March 31, 2022 was as follows: Number of Weighted- Weighted- Aggregate Outstanding as of December 31, 2021 11,507,643 $ 1.72 Exercised (654,935) 1.67 Cancelled/Forfeited (665,511) 1.67 Outstanding as of March 31, 2022 10,187,197 1.73 7.50 $ 143,555
Schedule of Restricted Stock Awards Activity	Restricted stock awards activity for the three months ended March 31, 2022 was as follows: Shares Weighted Average Outstanding as of December 31, 2021 666,298 $ 1.21 Forfeited (11,783) 1.22 Vested (168,144) 1.16 Outstanding as of March 31, 2022 486,371 1.23 A summary of the Company’s restricted stock units activity for the three months ended March 31, 2022 was as follows: Shares Weighted Average Outstanding as of December 31, 2021 11,983,032 $ 19.56 Granted 4,429,640 14.10 Forfeited (326,912) 17.94 Vested (1,494,932) 19.48 Outstanding as of March 31, 2022 14,590,828 17.92
Schedule of Stock-based Compensation Expense by Function	Stock-based compensation expense by function was as follows (in thousands): Three Months Ended March 31, 2022 2021 Cost of sales $ 1,786 $ 83 Research and development 7,102 762 Sales and marketing 2,868 186 General and administrative 14,942 806 Total $ 26,698 $ 1,837 Stock-based compensation expense by type of award was as follows (in thousands): Three Months Ended March 31, 2022 2021 Equity Classified Awards: Stock options $ 522 $ 163 RSAs (166) 1,674 RSUs 21,509 — Liability Classified Awards: Fixed value equity awards 1,780 — Optogration awards 3,053 — Total $ 26,698 $ 1,837

Leases (Tables)

Leases (Tables)	3 Months Ended
	Mar. 31, 2022
Leases [Abstract]
Schedule of Components of Lease Expenses, Supplemental Cash Flow Information, Weighted Average Remaining Terms, and Weighted Average Discount Rates	The components of lease expenses for were as follows (in thousands): Three Months Ended March 31, 2022 March 31, 2021 Operating lease cost $ 1,116 $ 1,174 Variable lease cost 385 459 Total operating lease cost $ 1,501 $ 1,633 Supplemental cash flow information related to leases was as follows (in thousands): Three Months Ended March 31, 2022 March 31, 2021 Cash paid for amounts included in the measurement of lease liabilities: Cash paid for operating leases included in operating activities $ (1,314) $ (1,219) Right of use assets obtained in exchange for lease obligations: Operating leases 5,746 2,876 Weighted average remaining terms were as follows (in years): March 31, 2022 December 31, 2021 Weighted average remaining lease term Operating leases 3.97 2.95 Weighted average discount rates were as follows: March 31, 2022 December 31, 2021 Weighted average discount rate Operating leases 3.62 % 2.80 %
Schedule of Supplemental Balance Sheet Information	Supplemental balance sheet information related to leases was as follows (in thousands): March 31, 2022 December 31, 2021 Operating leases: Operating lease right-of-use assets $ 14,005 $ 9,145 Operating lease liabilities: Operating lease liabilities, current $ 5,079 $ 4,735 Operating lease liabilities, non-current 10,102 5,768 Total operating lease liabilities $ 15,181 $ 10,503
Schedule of Maturities of Lease Liabilities	Maturities of lease liabilities were as follows (in thousands): Operating Leases Year Ending December 31, 2022 (remaining nine months) $ 3,993 2023 4,591 2024 2,373 2025 2,351 2026 1,795 2027 1,231 Thereafter 800 Total lease payments 17,134 Less: imputed interest (1,953) Total leases liabilities $ 15,181

Segment and Customer Concentr_2

Segment and Customer Concentration Information (Tables)	3 Months Ended
	Mar. 31, 2022
Segment Reporting [Abstract]
Schedule of Segment Operating Results and Reconciliations to the Consolidated Balances	The accounting policies of the operating segments are the same as those described in Note 2. Segment operating results and reconciliations to the Company’s consolidated balances are as follows (in thousands): Three Months Ended March 31, 2022 Autonomy Components Total Eliminations (1) Total Revenue: Revenues from external customers $ 5,898 $ 957 $ 6,855 $ — $ 6,855 Revenues from internal customer 2,361 2,156 4,517 (4,517) — Total revenue $ 8,259 $ 3,113 $ 11,372 $ (4,517) $ 6,855 Depreciation and amortization $ 544 $ 261 $ 805 $ — $ 805 Operating income (loss) (82,177) 270 (81,907) (424) (82,331) Other significant items: Segment assets 815,160 10,992 826,152 (18,352) 807,800 Inventories, net 9,813 199 10,012 — 10,012 Three Months Ended March 31, 2021 Autonomy Components Total Eliminations (1) Total Revenue: Revenues from external customers $ 4,336 $ 977 $ 5,313 $ — $ 5,313 Revenues from internal customer 1,275 1,142 2,417 (2,417) — Total revenue $ 5,611 $ 2,119 $ 7,730 $ (2,417) $ 5,313 Depreciation and amortization $ 638 $ 20 $ 658 $ (1) $ 657 Operating income (loss) (28,868) (237) (29,105) (139) (29,244) Other significant items: Segment assets 650,211 3,708 653,919 (2,705) 651,214 Inventories, net 3,245 38 3,283 — 3,283 (1) Represents the eliminations of all intercompany balances and transactions during the period presented.

Basis of Presentation and Sum_3

Basis of Presentation and Summary of Significant Accounting Policies - Concentration of Credit Risk (Details) - Accounts Receivable - Customer Concentration Risk	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Customer One
Concentration Risk [Line Items]
Percentage of accounts receivable (as percent)	39.00%	39.00%
Customer Two
Concentration Risk [Line Items]
Percentage of accounts receivable (as percent)	20.00%	31.00%
Customer Three
Concentration Risk [Line Items]
Percentage of accounts receivable (as percent)	11.00%
Customer Four
Concentration Risk [Line Items]
Percentage of accounts receivable (as percent)	10.00%

Revenue - Schedule of Disaggreg

Revenue - Schedule of Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Disaggregation of Revenue [Line Items]
Revenue	$ 6,855	$ 5,313
Revenue from contract with customer benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	100.00%	100.00%
Revenue from contract with customer benchmark | Revenue Recognition Timing Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	100.00%	100.00%
Revenue from contract with customer benchmark | Segment Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	100.00%	100.00%
Autonomy Solutions
Disaggregation of Revenue [Line Items]
Revenue	$ 5,898	$ 4,336
Autonomy Solutions | Revenue from contract with customer benchmark | Segment Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	86.00%	82.00%
Components
Disaggregation of Revenue [Line Items]
Revenue	$ 957	$ 977
Components | Revenue from contract with customer benchmark | Segment Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	14.00%	18.00%
Recognized at a point in time
Disaggregation of Revenue [Line Items]
Revenue	$ 1,541	$ 2,053
Recognized at a point in time | Revenue from contract with customer benchmark | Revenue Recognition Timing Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	22.00%	39.00%
Recognized over time
Disaggregation of Revenue [Line Items]
Revenue	$ 5,314	$ 3,260
Recognized over time | Revenue from contract with customer benchmark | Revenue Recognition Timing Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	78.00%	61.00%
North America
Disaggregation of Revenue [Line Items]
Revenue	$ 4,968	$ 2,539
North America | Revenue from contract with customer benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	73.00%	48.00%
Asia Pacific
Disaggregation of Revenue [Line Items]
Revenue	$ 1,860	$ 321
Asia Pacific | Revenue from contract with customer benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	27.00%	6.00%
Europe and Middle East
Disaggregation of Revenue [Line Items]
Revenue	$ 27	$ 2,453
Europe and Middle East | Revenue from contract with customer benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	0.00%	46.00%

Revenue - Narrative (Details)

Revenue - Narrative (Details) $ / shares in Units, $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2022USD ($)	Mar. 31, 2021USD ($)	Dec. 31, 2021USD ($)	Dec. 31, 2020USD ($)	Mar. 31, 2020USD ($)tranche$ / sharesshares
Class of Warrant or Right [Line Items]
Fair value of warrants outstanding	$ 16,399		$ 31,230
Change in fair value of warrant liabilities	(3,857)	$ (46,649)
Contract assets	14,772		9,907	$ 0
Contract liabilities	$ 900		900
VCTF warrant
Class of Warrant or Right [Line Items]
Number of tranches | tranche					2
Fair value of warrants outstanding					$ 2,900
Change in fair value of warrant liabilities			$ 1,000
Class A Common Stock | VCTF warrant
Class of Warrant or Right [Line Items]
Conversion of warrants into securities (in shares) | shares					4,089,280
Stock price of warrants (in dollars per share) | $ / shares					$ 3.1769

Revenue - Schedule of Significa

Revenue - Schedule of Significant Changes in Contract Assets and Contract Liabilities (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Contract With Customer Asset [Roll Forward]
Beginning balance	$ 9,907	$ 0
Revenue recognized for performance obligations that have been satisfied but for which amounts have not been billed	4,865	9,907
Ending balance	14,772	9,907
Contract with Customer, Liability [Roll Forward]
Beginning balance	898	2,284
Revenue recognized that was included in the contract liabilities beginning balance	(250)	(1,792)
Net increase due to cash received and not recognized as revenue and billings in excess of revenue recognized during the period	259	406
Ending balance	$ 907	$ 898

Investments - Amortized Cost (D

Investments - Amortized Cost (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Debt Securities, Available-for-sale [Line Items]
Cost	$ 586,552	$ 419,783
Gross Unrealized Gains	3	14
Gross Unrealized Losses	(4,559)	(922)
Fair Value	581,996	418,875
Included in cash and cash equivalents
Debt Securities, Available-for-sale [Line Items]
Cost	80,201	950
Gross Unrealized Gains	2	0
Gross Unrealized Losses	(28)	0
Fair Value	80,175	950
Included in marketable securities
Debt Securities, Available-for-sale [Line Items]
Cost	506,351	418,833
Gross Unrealized Gains	1	14
Gross Unrealized Losses	(4,531)	(922)
Fair Value	501,821	417,925
U.S. treasury securities
Debt Securities, Available-for-sale [Line Items]
Cost	251,673	161,938
Gross Unrealized Gains	1	1
Gross Unrealized Losses	(2,685)	(474)
Fair Value	248,989	161,465
U.S. agency and government sponsored securities
Debt Securities, Available-for-sale [Line Items]
Cost	4,996	4,995
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(89)	(25)
Fair Value	4,907	4,970
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Cost	130,103	40,788
Gross Unrealized Gains	1	0
Gross Unrealized Losses	(126)	(4)
Fair Value	129,978	40,784
Corporate bonds
Debt Securities, Available-for-sale [Line Items]
Cost	158,595	165,522
Gross Unrealized Gains	1	13
Gross Unrealized Losses	(1,348)	(345)
Fair Value	157,248	165,190
Asset-backed securities
Debt Securities, Available-for-sale [Line Items]
Cost	41,185	46,540
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(311)	(74)
Fair Value	$ 40,874	$ 46,466

Investments - Continuous Loss P

Investments - Continuous Loss Position (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Debt Securities, Available-for-sale [Line Items]
Gross Unrealized Losses	$ (4,559)	$ (922)
Fair Value	546,000	372,482
U.S. treasury securities
Debt Securities, Available-for-sale [Line Items]
Gross Unrealized Losses	(2,685)	(474)
Fair Value	228,993	146,454
U.S. agency and government sponsored securities
Debt Securities, Available-for-sale [Line Items]
Gross Unrealized Losses	(89)	(25)
Fair Value	4,907	4,970
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Gross Unrealized Losses	(126)	(4)
Fair Value	114,980	30,285
Corporate bonds
Debt Securities, Available-for-sale [Line Items]
Gross Unrealized Losses	(1,348)	(345)
Fair Value	156,246	145,522
Asset-backed securities
Debt Securities, Available-for-sale [Line Items]
Gross Unrealized Losses	(311)	(74)
Fair Value	$ 40,874	$ 45,251

Investments - Schedule of Equit

Investments - Schedule of Equity Investments (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Debt Securities, Available-for-sale [Line Items]
Marketable equity investments	$ 103,118	$ 79,872
Money market funds | Cash and cash equivalents
Debt Securities, Available-for-sale [Line Items]
Marketable equity investments	47,497	25,654
Marketable equity investments | Marketable securities
Debt Securities, Available-for-sale [Line Items]
Marketable equity investments	45,619	44,216
Non-Marketable Equity Investment | Other non-current assets
Debt Securities, Available-for-sale [Line Items]
Non-marketable equity investment measured using the measurement alternative	$ 10,002	$ 10,002

Investments - Narrative (Detail

Investments - Narrative (Details) - Robotic Research OpCo, LLC - USD ($) $ in Millions	1 Months Ended	3 Months Ended
	Dec. 31, 2021	Mar. 31, 2022
Debt Securities, Available-for-sale [Line Items]
Investment in Robotic Research, percentage of capitalization (percent, less than)	5.00%
Class A Preferred Units
Debt Securities, Available-for-sale [Line Items]
Sale of stock (in shares)	1,495
Class A Common Stock
Debt Securities, Available-for-sale [Line Items]
Stock consideration	$ 10
Common stock, shares issued (in shares)		618,924

Financial Statement Component_2

Financial Statement Components - Cash and Cash Equivalents (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash	$ 31,744	$ 303,373
Money market funds	47,497	25,654
U.S. treasury securities	19,997	0
Commercial paper	60,178	950
Total cash and cash equivalents	$ 159,416	$ 329,977

Financial Statement Component_3

Financial Statement Components - Inventories, net (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Raw materials	$ 6,535		$ 5,866
Work-in-process	2,265		1,171
Finished goods	1,212		3,305
Total inventories, net	10,012	$ 3,283	$ 10,342
Inventory write-downs	$ 1,356	$ 257

Financial Statement Component_4

Financial Statement Components - Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Prepaid expenses	$ 15,893	$ 14,651
Contract assets	14,772	9,907
Advance payments to vendors	4,417	1,810
Other receivables	2,463	2,827
Prepaid expenses and other current assets	$ 37,545	$ 29,195

Financial Statement Component_5

Financial Statement Components - Property and Equipment (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 23,956		$ 17,787
Accumulated depreciation and amortization	(7,519)		(6,778)
Total property and equipment, net	16,437		11,009
Depreciation and amortization	700	$ 700
Machinery and equipment
Property, Plant and Equipment [Line Items]
Total property and equipment	8,286		7,694
Computer hardware and software
Property, Plant and Equipment [Line Items]
Total property and equipment	2,871		2,854
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total property and equipment	885		869
Vehicles, including demonstration fleet
Property, Plant and Equipment [Line Items]
Total property and equipment	2,631		2,421
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Total property and equipment	829		272
Construction in progress
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 8,454		$ 3,677

Financial Statement Component_6

Financial Statement Components - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Beginning of the period	$ 2,424
Amortization	(63)
End of the period	2,361		$ 2,424
OptoGration
Finite-Lived Intangible Assets [Line Items]
Amortization	(100)	$ 0
Gross Carrying Amount	2,650		2,650
Accumulated Amortization	(289)		(226)
Net Carrying Amount	$ 2,361		$ 2,424
Weighted Average Remaining Period (Years)	9 years 3 months 18 days		9 years 7 months 6 days
OptoGration | Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 780		$ 780
Accumulated Amortization	(52)		(33)
Net Carrying Amount	$ 728		$ 747
Weighted Average Remaining Period (Years)	9 years 3 months 18 days		9 years 7 months 6 days
OptoGration | Tradename
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 120		$ 120
Accumulated Amortization	(120)		(120)
Net Carrying Amount	0		0
OptoGration | Developed technology
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	1,750		1,750
Accumulated Amortization	(117)		(73)
Net Carrying Amount	$ 1,633		$ 1,677
Weighted Average Remaining Period (Years)	9 years 3 months 18 days		9 years 7 months 6 days

Financial Statement Component_7

Financial Statement Components - Future Amortization Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Amortization	$ 63
OptoGration
Finite-Lived Intangible Assets [Line Items]
Remaining 2022	190
2023	253
2024	253
2025	253
2026	253
Thereafter	1,159
Net Carrying Amount	2,361		$ 2,424
Amortization	$ 100	$ 0

Financial Statement Component_8

Financial Statement Components - Goodwill (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Goodwill [Line Items]
Goodwill	$ 2,945	$ 3,110
Autonomy Solutions
Goodwill [Line Items]
Goodwill	687	687
Components
Goodwill [Line Items]
Goodwill	$ 2,258	$ 2,423

Financial Statement Component_9

Financial Statement Components - Other Noncurrent Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Security deposits	$ 2,574	$ 1,187
Non-marketable equity investment	10,002	10,002
Other non-current assets	1,097	1,266
Other non-current assets	$ 13,673	$ 12,455

Financial Statement Componen_10

Financial Statement Components - Accrued and Other Current Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued compensation and benefits	$ 13,755	$ 9,899
Accrued expenses	6,431	6,727
Warranty reserves	1,401	1,798
Accrued interest payable	2,242	316
Other	1,019	1,104
Accrued and other current liabilities	$ 24,848	$ 19,844

Convertible Senior Notes and _3

Convertible Senior Notes and Capped Call Transactions - Additional Information (Details)	1 Months Ended					3 Months Ended
	Dec. 31, 2021USD ($)$ / shares	Dec. 31, 2021USD ($)$ / shares	Dec. 31, 2021USD ($)tradingDay$ / shares	Dec. 31, 2021USD ($)consecutiveTradingDay$ / shares	Dec. 31, 2021USD ($)consecutiveBusinessDay$ / shares	Mar. 31, 2022USD ($)$ / sharesshares
Debt Instrument [Line Items]
Stock option, capped calls, initial strike price | $ / shares	$ 19.98	$ 19.98	$ 19.98	$ 19.98	$ 19.98
Stock option, capped calls, initial cap price | $ / shares	$ 30.16	$ 30.16	$ 30.16	$ 30.16	$ 30.16
Class A Common Stock
Debt Instrument [Line Items]
Common stock, par value (in dollars per share) | $ / shares						$ 0.0001
Convertible Senior Notes Due 2026 | Convertible Debt
Debt Instrument [Line Items]
Principal	$ 625,000,000	$ 625,000,000	$ 625,000,000	$ 625,000,000	$ 625,000,000	$ 625,000,000
Interest rate (as a percent)	1.25%	1.25%	1.25%	1.25%	1.25%
Proceeds from the issuance of debt	$ 75,000,000
Proceeds from convertible debt	$ 609,400,000
Debt instrument, convertible, shares issuable | shares						50.0475
Conversion price (in dollars per share) | $ / shares	$ 19.98	$ 19.98	$ 19.98	$ 19.98	$ 19.98
Debt issuance costs, net	$ 16,200,000	$ 16,200,000	$ 16,200,000	$ 16,200,000	$ 16,200,000
Note term (in months)						4 years 8 months 12 days
Accrued interest repaid						$ 1,900,000
Payments to purchase capped calls						$ 73,400,000
Convertible Senior Notes Due 2026 | Convertible Debt | Debt Instrument, Redemption, Period One
Debt Instrument [Line Items]
Debt instrument, convertible, threshold trading days | tradingDay			20
Debt instrument, convertible, threshold consecutive trading days | consecutiveTradingDay				30
Debt instrument, redemption price, percentage		100.00%
Convertible Senior Notes Due 2026 | Convertible Debt | Debt Instrument, Redemption, Period Two
Debt Instrument [Line Items]
Debt instrument, convertible, threshold percentage of stock price trigger		130.00%
Debt instrument, convertible, threshold trading days | tradingDay			20
Debt instrument, convertible, threshold consecutive trading days | consecutiveTradingDay				30
Convertible Senior Notes Due 2026 | Convertible Debt | Debt Instrument, Redemption, Period Three
Debt Instrument [Line Items]
Debt instrument, convertible, threshold trading days				10	5
Debt instrument, convertible, threshold percent of conversion price triggering convertible feature		98.00%
Convertible Senior Notes Due 2026 | Convertible Debt | Class A Common Stock
Debt Instrument [Line Items]
Common stock, par value (in dollars per share) | $ / shares	$ 0.0001	$ 0.0001	$ 0.0001	$ 0.0001	$ 0.0001
Convertible Senior Notes Due 2026 | Convertible Debt | Class A Common Stock | Debt Instrument, Redemption, Period One
Debt Instrument [Line Items]
Debt instrument, convertible, threshold percentage of stock price trigger		130.00%

Convertible Senior Notes and _4

Convertible Senior Notes and Capped Call Transactions - Schedule of Net Carrying Amount (Details) - Convertible Senior Notes Due 2026 - Convertible Debt - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Principal	$ 625,000,000	$ 625,000,000
Unamortized debt discount and issuance costs	(15,234,000)	(16,043,000)
Net carrying amount	$ 609,766,000	$ 608,957,000

Convertible Senior Notes and _5

Convertible Senior Notes and Capped Call Transactions - Schedule of Interest Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Debt Instrument [Line Items]
Interest expense and other	$ 3,280	$ 200
Convertible Senior Notes Due 2026 | Convertible Debt
Debt Instrument [Line Items]
Contractual interest expense	1,926
Amortization of premium on marketable securities	809
Interest expense and other	$ 2,735

Fair Value Measurements - Narra

Fair Value Measurements - Narrative (Details) $ in Millions	Mar. 31, 2022USD ($)	Dec. 31, 2021USD ($)
Level 3 | Expected Term | Private Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants term (in years)	3 years 8 months 4 days
Level 3 | Price Volatility | Private Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants outstanding, measurement input	0.756
Level 3 | Risk-Free Interest Rate | Private Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants outstanding, measurement input	0.0244
Level 2
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Convertible senior notes, fair value	$ 631.9	$ 669.4

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Changes in Level 3 Liabilities Measured at Fair Value (Details) - Warrants - Private Warrants $ in Thousands	3 Months Ended
	Mar. 31, 2022USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at beginning of period	$ 31,230
Change in fair value prior to exercise in January 2022	4,586
Exercises in January 2022	(18,688)
Other measurement adjustments	(729)
Balance at end of period	$ 16,399

Fair Value Measurements - Sch_2

Fair Value Measurements - Schedule of Financial Assets and Liabilities Subject to Fair Value Measurements on a Recurring Basis and the Level of Inputs Used (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Assets:
Marketable investments:	$ 581,996	$ 418,875
Liabilities:
Warrant liabilities	16,399	31,230
U.S. treasury securities
Assets:
Marketable investments:	248,989	161,465
U.S. agency and government sponsored securities
Assets:
Marketable investments:	4,907	4,970
Corporate bonds
Assets:
Marketable investments:	157,248	165,190
Asset-backed securities
Assets:
Marketable investments:	40,874	46,466
Fair Value, Recurring
Assets:
Total cash equivalents	127,672	26,604
Equity investments	45,619	44,216
Total marketable investments	547,440	462,141
Liabilities:
Warrant liabilities	16,399	31,230
Fair Value, Recurring | Private Warrants
Liabilities:
Warrant liabilities	16,399	31,230
Fair Value, Recurring | U.S. treasury securities
Assets:
Marketable investments:	228,992	161,465
Fair Value, Recurring | U.S. agency and government sponsored securities
Assets:
Marketable investments:	4,907	4,970
Fair Value, Recurring | Commercial paper
Assets:
Marketable investments:	69,800	39,834
Fair Value, Recurring | Corporate bonds
Assets:
Marketable investments:	157,248	165,190
Fair Value, Recurring | Asset-backed securities
Assets:
Marketable investments:	40,874	46,466
Fair Value, Recurring | Money market funds
Assets:
Total cash equivalents	47,497	25,654
Fair Value, Recurring | U.S. treasury securities
Assets:
Total cash equivalents	19,997
Fair Value, Recurring | Commercial paper
Assets:
Total cash equivalents	60,178	950
Level 1 | Fair Value, Recurring
Assets:
Total cash equivalents	67,494	25,654
Equity investments	45,619	44,216
Total marketable investments	274,611	205,681
Liabilities:
Warrant liabilities	0	0
Level 1 | Fair Value, Recurring | Private Warrants
Liabilities:
Warrant liabilities	0	0
Level 1 | Fair Value, Recurring | U.S. treasury securities
Assets:
Marketable investments:	228,992	161,465
Level 1 | Fair Value, Recurring | U.S. agency and government sponsored securities
Assets:
Marketable investments:	0	0
Level 1 | Fair Value, Recurring | Commercial paper
Assets:
Marketable investments:	0	0
Level 1 | Fair Value, Recurring | Corporate bonds
Assets:
Marketable investments:	0	0
Level 1 | Fair Value, Recurring | Asset-backed securities
Assets:
Marketable investments:	0	0
Level 1 | Fair Value, Recurring | Money market funds
Assets:
Total cash equivalents	47,497	25,654
Level 1 | Fair Value, Recurring | U.S. treasury securities
Assets:
Total cash equivalents	19,997
Level 1 | Fair Value, Recurring | Commercial paper
Assets:
Total cash equivalents	0	0
Level 2 | Fair Value, Recurring
Assets:
Total cash equivalents	60,178	950
Equity investments	0	0
Total marketable investments	272,829	256,460
Liabilities:
Warrant liabilities	0	0
Level 2 | Fair Value, Recurring | Private Warrants
Liabilities:
Warrant liabilities	0	0
Level 2 | Fair Value, Recurring | U.S. treasury securities
Assets:
Marketable investments:	0	0
Level 2 | Fair Value, Recurring | U.S. agency and government sponsored securities
Assets:
Marketable investments:	4,907	4,970
Level 2 | Fair Value, Recurring | Commercial paper
Assets:
Marketable investments:	69,800	39,834
Level 2 | Fair Value, Recurring | Corporate bonds
Assets:
Marketable investments:	157,248	165,190
Level 2 | Fair Value, Recurring | Asset-backed securities
Assets:
Marketable investments:	40,874	46,466
Level 2 | Fair Value, Recurring | Money market funds
Assets:
Total cash equivalents	0	0
Level 2 | Fair Value, Recurring | U.S. treasury securities
Assets:
Total cash equivalents	0
Level 2 | Fair Value, Recurring | Commercial paper
Assets:
Total cash equivalents	60,178	950
Level 3 | Fair Value, Recurring
Assets:
Total cash equivalents	0	0
Equity investments	0	0
Total marketable investments	0	0
Liabilities:
Warrant liabilities	16,399	31,230
Level 3 | Fair Value, Recurring | Private Warrants
Liabilities:
Warrant liabilities	16,399	31,230
Level 3 | Fair Value, Recurring | U.S. treasury securities
Assets:
Marketable investments:	0	0
Level 3 | Fair Value, Recurring | U.S. agency and government sponsored securities
Assets:
Marketable investments:	0	0
Level 3 | Fair Value, Recurring | Commercial paper
Assets:
Marketable investments:	0	0
Level 3 | Fair Value, Recurring | Corporate bonds
Assets:
Marketable investments:	0	0
Level 3 | Fair Value, Recurring | Asset-backed securities
Assets:
Marketable investments:	0	0
Level 3 | Fair Value, Recurring | Money market funds
Assets:
Total cash equivalents	0	0
Level 3 | Fair Value, Recurring | U.S. treasury securities
Assets:
Total cash equivalents	0
Level 3 | Fair Value, Recurring | Commercial paper
Assets:
Total cash equivalents	$ 0	$ 0

Earnings (Loss) Per Share - Bas

Earnings (Loss) Per Share - Basic and Diluted Loss Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Numerator:
Net loss	$ (88,333)	$ (75,923)
Denominator:
Weighted average common shares outstanding- Basic (in shares)	348,683,836	332,987,523
Weighted average common shares outstanding- Diluted (in shares)	348,683,836	332,987,523
Net loss per shares attributable to common shareholders- Basic (in dollars per share)	$ (0.25)	$ (0.23)
Net loss per shares attributable to common shareholders- Diluted (in dollars per share)	$ (0.25)	$ (0.23)

Earnings (Loss) Per Share - Ant

Earnings (Loss) Per Share - Antidilutive Securities (Details)	3 Months Ended
	Mar. 31, 2022shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total (in shares)	74,389,181
Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total (in shares)	5,776,772
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total (in shares)	10,187,197
Restricted stock awards and restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total (in shares)	15,077,199
Liability classified RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total (in shares)	2,628,407
Vendor stock-in-lieu of cash program
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total (in shares)	833,173
Convertible Senior Notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total (in shares)	31,279,716
Earn-out shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total (in shares)	8,606,717

Earnings (Loss) Per Share - Nar

Earnings (Loss) Per Share - Narrative (Details)	Mar. 31, 2022$ / shares
Convertible Senior Notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Conversion price (in dollars per share)	$ 19.981

Stockholders' Equity (Details)

Stockholders' Equity (Details) $ / shares in Units, $ in Thousands	1 Months Ended	3 Months Ended
	Jan. 31, 2022shares	Mar. 31, 2022USD ($)vote$ / sharesshares	Mar. 31, 2021USD ($)	Dec. 31, 2021shares
Class of Stock [Line Items]
Vendor payments in shares in lieu of cash (in shares)		674,350
Vendor payments in stock in lieu of cash, liability | $		$ 2,500
Compensation expense | $		26,698	$ 1,837
Daimler North America Corporation
Class of Stock [Line Items]
Prepaid expenses and other current assets related to stock-in-lieu of cash program | $		9,200
Research and development
Class of Stock [Line Items]
Compensation expense | $		7,102	$ 762
Research and development | Daimler North America Corporation
Class of Stock [Line Items]
Compensation expense | $		$ 2,000
Public Warrants
Class of Stock [Line Items]
Warrants outstanding (in shares)				0
Private Warrants
Class of Stock [Line Items]
Warrants outstanding (in shares)		1,687,492		3,077,021
Warrants exercised (in shares)	1,389,529
Shares issued for exercise of warrants (in shares)	401,365
Share per warrant (in shares)		1
Stock price of warrants (in dollars per share) | $ / shares		$ 11.50
Class A Common Stock
Class of Stock [Line Items]
Common stock, shares authorized (in shares)		715,000,000
Common stock, par value (in dollars per share) | $ / shares		$ 0.0001
Common stock, shares issued (in shares)		269,978,536
Common stock, shares outstanding (in shares)		269,978,536
Common stock, votes per share | vote		1
Shares issued for exercise of warrants (in shares)		401,365
Class A Common Stock | Daimler North America Corporation
Class of Stock [Line Items]
Vendor payments in shares in lieu of cash (in shares)		1,500,000
Award vesting period (in years and in months)		2 years
Shares issued in period (in shares)		750,000
Class B Common Stock
Class of Stock [Line Items]
Common stock, shares authorized (in shares)		121,000,000
Common stock, par value (in dollars per share) | $ / shares		$ 0.0001
Common stock, shares issued (in shares)		97,088,670
Common stock, shares outstanding (in shares)		97,088,670
Common stock, votes per share | vote		10

Stockholders' Equity - Stock-in

Stockholders' Equity - Stock-in-lieu of Cash Program Activity (Details)	3 Months Ended
	Mar. 31, 2022$ / sharesshares
Shares
Outstanding at beginning of period (in shares) | shares	11,507,643
Outstanding at end of period (in shares) | shares	10,187,197
Weighted- Average Exercise Price
Outstanding at beginning of period (in dollars per share) | $ / shares	$ 1.72
Outstanding at end of period (in dollars per share) | $ / shares	$ 1.73
Vendor stock-in-lieu of cash program
Shares
Outstanding at beginning of period (in shares) | shares	1,500,000
Granted (in shares) | shares	674,350
Vested (in shares) | shares	(1,424,350)
Outstanding at end of period (in shares) | shares	750,000
Weighted- Average Exercise Price
Outstanding at beginning of period (in dollars per share) | $ / shares	$ 15.72
Granted (in dollars per share) | $ / shares	12.93
Vested (in dollars per share) | $ / shares	14.09
Outstanding at end of period (in dollars per share) | $ / shares	$ 15.72

Stock-based Compensation - Narr

Stock-based Compensation - Narrative (Details) - USD ($) $ in Thousands	Aug. 03, 2021	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2020	Jun. 30, 2019	Mar. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Intrinsic value of stock options exercised		$ 8,300
Fair value of options vested		800
Stock-based compensation expense		26,698	$ 1,837
OptoGration
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense		$ 9,100
Contingent stock consideration	$ 22,000
2020 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares authorized for issuance (in shares)		36,588,278				36,588,278
Stock options | 2015 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years and in months)		4 years
Award expiration period (in years)		10 years
Stock options | Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years and in months)		1 year
Stock options | Tranche One | 2015 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage		25.00%
Stock options | Tranche Two | 2015 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years and in months)		36 months
Award vesting percentage		75.00%
Restricted stock awards and restricted stock units | Share-based Payment Arrangement, Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years and in months)					4 years
Granted (in shares)						0
Restricted stock awards and restricted stock units | Share-based Payment Arrangement, Employee | Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years and in months)				1 year
Award vesting percentage					25.00%
Restricted stock awards and restricted stock units | Share-based Payment Arrangement, Employee | Tranche Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years and in months)					36 months
Award vesting percentage					75.00%
Fixed value equity awards | Share-based Payment Arrangement, Employee | 2020 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years and in months)		4 years
Stock-based compensation expense		$ 1,800	$ 0
Fixed value equity awards | Share-based Payment Arrangement, Employee | Tranche One | 2020 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage		25.00%
Fixed value equity awards | Share-based Payment Arrangement, Employee | Tranche Two | 2020 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage		25.00%
Fixed value equity awards | Share-based Payment Arrangement, Employee | Tranche Three | 2020 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage		25.00%
Fixed value equity awards | Share-based Payment Arrangement, Employee | Tranche Four | 2020 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting percentage		25.00%
RSUs | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period (in years and in months)		6 years
RSUs | Share-based Payment Arrangement, Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)		4,429,640

Stock-based Compensation - Stoc

Stock-based Compensation - Stock Option Activity (Details) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2022USD ($)$ / sharesshares
Number of Common Stock Options
Outstanding at beginning of period (in shares) | shares	11,507,643
Exercised (in shares) | shares	(654,935)
Forfeited (in shares) | shares	(665,511)
Outstanding at end of period (in shares) | shares	10,187,197
Weighted- Average Exercise Price
Outstanding at beginning of period (in dollars per share) | $ / shares	$ 1.72
Exercised (in dollars per share) | $ / shares	1.67
Forfeited (in dollars per share) | $ / shares	1.67
Outstanding at end of period (in dollars per share) | $ / shares	$ 1.73
Weighted- Average Remaining Contractual Life (Years)
Outstanding balance	7 years 6 months
Aggregate Intrinsic Value (In Thousands)
Outstanding balance | $	$ 143,555

Stock-based Compensation - Rest

Stock-based Compensation - Restricted Stock Activity (Details)	3 Months Ended
	Mar. 31, 2022$ / sharesshares
Restricted stock awards and restricted stock units
Shares
Outstanding at beginning of period (in shares) | shares	666,298
Forfeited (in shares) | shares	(11,783)
Vested (in shares) | shares	(168,144)
Outstanding at end of period (in shares) | shares	486,371
Weighted Average Grant Date Fair Value per Share
Outstanding at beginning of period (in dollars per share)	$ 1.21
Forfeited (in dollars per share)	1.22
Vested (in dollars per share)	1.16
Outstanding at end of period (in dollars per share)	$ 1.23
RSUs
Shares
Outstanding at beginning of period (in shares) | shares	11,983,032
Forfeited (in shares) | shares	(326,912)
Vested (in shares) | shares	(1,494,932)
Outstanding at end of period (in shares) | shares	14,590,828
Weighted Average Grant Date Fair Value per Share
Outstanding at beginning of period (in dollars per share)	$ 19.56
Granted (in dollars per share)	14.10
Forfeited (in dollars per share)	17.94
Vested (in dollars per share)	19.48
Outstanding at end of period (in dollars per share)	$ 17.92

Stock-based Compensation - Comp

Stock-based Compensation - Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	$ 26,698	$ 1,837
Fixed value equity awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	1,780	0
Optogration awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	3,053	0
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	522	163
RSAs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	(166)	1,674
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	21,509	0
Cost of sales
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	1,786	83
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	7,102	762
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	2,868	186
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	$ 14,942	$ 806

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Tax Disclosure [Abstract]
Provision for income taxes	$ 404	$ 0
Effective tax rate, percent	0.50%	0.00%

Leases - Narrative (Details)

Leases - Narrative (Details) - renewalOption	3 Months Ended
	Mar. 31, 2022	Oct. 31, 2021
Lessee, Lease, Description [Line Items]
Term of lease (in moths)		65 months
Minimum
Lessee, Lease, Description [Line Items]
Number of renewal options	1
Renewal lease term (in years)	1 year
Maximum
Lessee, Lease, Description [Line Items]
Renewal lease term (in years)	6 years

Leases - Components of Lease Ex

Leases - Components of Lease Expenses (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Leases [Abstract]
Operating lease cost	$ 1,116	$ 1,174
Variable lease cost	385	459
Total operating lease cost	$ 1,501	$ 1,633

Leases - Supplemental Cash Flow

Leases - Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash paid for amounts included in the measurement of lease liabilities:
Cash paid for operating leases included in operating activities	$ (1,314)	$ (1,219)
Right of use assets obtained in exchange for lease obligations:
Operating leases	$ 5,746	$ 2,876

Leases - Supplemental Balance S

Leases - Supplemental Balance Sheet Information, Weighted Average Remaining Terms, and Weighted Average Discount Rates (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Operating leases:
Operating lease right-of-use assets	$ 14,005	$ 9,145
Operating lease liabilities, current	5,079	4,735
Operating lease liabilities, non-current	10,102	5,768
Total operating lease liabilities	$ 15,181	$ 10,503
Weighted average remaining lease term
Operating leases (in years)	3 years 11 months 19 days	2 years 11 months 12 days
Weighted average discount rate
Operating leases (as a percent)	3.62%	2.80%

Leases - Maturities of Lease Li

Leases - Maturities of Lease Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Operating Leases
2022 (remaining nine months)	$ 3,993
2023	4,591
2024	2,373
2025	2,351
2026	1,795
2027	1,231
Thereafter	800
Total lease payments	17,134
Less: imputed interest	(1,953)
Total leases liabilities	$ 15,181	$ 10,503

Commitment and Contingencies -

Commitment and Contingencies - Narrative (Details) - USD ($) $ in Millions	1 Months Ended	3 Months Ended
	Oct. 31, 2021	Sep. 30, 2021	Mar. 31, 2022
Other Commitments [Line Items]
Purchase obligations			$ 39.1
Accrued rent	$ 5
Variable lease costs	$ 1.4
P3 USA, Inc.
Other Commitments [Line Items]
Purchase commitment			$ 30
Class A Common Stock | P3 USA, Inc.
Other Commitments [Line Items]
Shares issued for services (in shares)		291,940

Segment and Customer Concentr_3

Segment and Customer Concentration Information - Segment Operating Results and Reconciliation to the Consolidated Balances (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Revenue:
Revenue	$ 6,855	$ 5,313
Depreciation and amortization	805	657
Operating income (loss)	(82,331)	(29,244)
Other significant items:
Segment assets	807,800	651,214	$ 883,536
Inventories, net	10,012	3,283	$ 10,342
Reportable Segments
Revenue:
Revenue	11,372	7,730
Depreciation and amortization	805	658
Operating income (loss)	(81,907)	(29,105)
Other significant items:
Segment assets	826,152	653,919
Inventories, net	10,012	3,283
Eliminations
Revenue:
Revenue	(4,517)	(2,417)
Depreciation and amortization	0	(1)
Operating income (loss)	(424)	(139)
Other significant items:
Segment assets	(18,352)	(2,705)
Inventories, net	0	0
Autonomy Solutions
Revenue:
Revenue	5,898	4,336
Autonomy Solutions | Reportable Segments
Revenue:
Revenue	8,259	5,611
Depreciation and amortization	544	638
Operating income (loss)	(82,177)	(28,868)
Other significant items:
Segment assets	815,160	650,211
Inventories, net	9,813	3,245
Autonomy Solutions | Eliminations
Revenue:
Revenue	(2,361)	(1,275)
Components
Revenue:
Revenue	957	977
Components | Reportable Segments
Revenue:
Revenue	3,113	2,119
Depreciation and amortization	261	20
Operating income (loss)	270	(237)
Other significant items:
Segment assets	10,992	3,708
Inventories, net	199	38
Components | Eliminations
Revenue:
Revenue	$ (2,156)	$ (1,142)

Segment and Customer Concentr_4

Segment and Customer Concentration Information - Narrative (Details) - Revenue from contract with customer benchmark - Customer Concentration Risk	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Customer One
Concentration Risk [Line Items]
Percentage of revenue (as percent)	52.00%
Customer Two
Concentration Risk [Line Items]
Percentage of revenue (as percent)	23.00%
Largest Customer
Concentration Risk [Line Items]
Percentage of revenue (as percent)		45.00%

Related Party Transactions (Det

Related Party Transactions (Details) - Mr. Heng - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Mar. 31, 2022	Feb. 28, 2021
Related Party Transaction [Line Items]
Investment	$ 12.1		$ 15
Portion of investment sold	$ 2.9
Investment, fair value		$ 12.3

Subsequent Events - Additional

Subsequent Events - Additional Information (Details) - Chief Executive Officer - RSUs - Subsequent Event shares in Millions	May 02, 2022tradingDay$ / sharesshares
Subsequent Event [Line Items]
Granted (in shares) | shares	10.8
Consecutive trading days | tradingDay	90
Service period (in years)	7 years
Achievement of $50 stock price
Subsequent Event [Line Items]
RSU vesting, market condition, stock price (in dollars per share)	$ 50
Achievement of $60 stock price
Subsequent Event [Line Items]
RSU vesting, market condition, stock price (in dollars per share)	60
Achievement of $70 stock price
Subsequent Event [Line Items]
RSU vesting, market condition, stock price (in dollars per share)	$ 70